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Abstract
A key problem in medical research and practice is that of accurately identi-
fying endpoints or times-to-event in stages of disease progression or treatment
outcomes. In chronic or long-term conditions such as Human Immunodeficiency
Virus (HIV) infection, the reaching of the endpoint is determined by comparing
an individual’s biomarker measurements over a period of time to a pre-determined
threshold. The small number and irregular spacing of such measurements often
make it difficult to determine when a patient has truly reached the endpoint, and
current methods do not take this uncertainty into account.
In this thesis, we consider the impact of endpoint uncertainty on statistical infer-
ences in Cox regression for time-to-event data, review the current use of weights
on individuals in Cox modelling, and propose a novel approach of weighting an
individual’s biomarker measurement times, based on schemes which determine
the probability of that biomarker measurement being indicative of a true end-
point. Two weighting schemes are developed and illustrated — the first-of-two
weighting (FOTW) scheme, based on the practice of taking the first of two con-
secutive above-threshold measurements as the endpoint measurement (termed the
first-of-two unweighted, or FOT U/W scheme); and the longitudinal conditional
probability weighting (LCPW) scheme, which applies weights to all measurements
based on a longitudinal mixed-effects model (LMEM) of the data.
We show through simulations that both the FOTW and LCPW schemes have
good power in detecting significant differences between study groups using Cox
analysis but are sensitive to differences in observational frequency between the
groups, and we explore the robustness of the LCPW scheme to misspecifications
of the LMEM. Finally, we illustrate the use of these schemes on a dataset from
the Western Australian HIV study and discuss areas for future investigation,
including ways to improve the reliability and robustness of the schemes.
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1.1 The problem of uncertainty in biomedical
analyses
In medical research and practice, patients are often assigned to status categories
based on various diagnostic measures which may involve a degree of subjective
assessment or uncertainty. Such classifications are usually based on extensive
observation by which researchers and clinicians determine reasonable diagnos-
tic characteristics for each category. They provide researchers with well-defined
groups to compare and serve as guidelines to clinicians regarding disease progres-
sion and therapy goals. Classifications are not free from error in many instances,
however, as most classifications are based on some combination of measurement,
patient self-reporting, and clinician opinion, all of which have inherent variabil-
ity. Hence each patient is categorized based on one of many theoretically possible
assessments, specific to the day, time, or other characteristic of that particular
examination, and the true category to which a patient belongs may be unknown
or latent. A problem closely related to this is that of uncertainty in identifying
endpoints in disease progression – timepoints at which a subject moves from one
category to another.
Currently, most statistical methods used in clinical research fail to recognize pos-
sible misclassifications and the underlying uncertainty of such assessments, as-
suming that no error exists and that endpoints are well-defined. However, in
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some cases error rates could be substantial and affect conclusions of statistical
significance or non-significance, seriously impacting the accuracy of inferences
drawn from research data and their implementation in medical treatment and
policy.
1.1.1 Endpoint identification in HIV research
The problem of accurately identifying endpoints in disease progression or treat-
ment outcomes is especially important to studies involving chronic or long-term
conditions. For example, a clinic specializing in antiretroviral therapy (ART)
against the Human Immunodeficiency Virus (HIV) may track its patients’ CD4
T-cell (henceforth referred to simply as CD4) counts as a means of measuring how
well they are responding to treatment. Patients may be deemed to have had a
successful treatment outcome if their blood CD4 counts have reached or surpassed
a threshold of say, 500 cells per cubic millimetre (mm3). In statistical terms, they
have reached the endpoint, and moved from the category of “unsuccessful” to
“successful” in treatment outcome.
Two issues complicate the accurate identification of endpoints defined by CD4
counts. Firstly, patient visits to HIV clinics tend to be irregular, being spaced
anywhere between three months to more than one year apart. Most commonly,
patients tend to visit clinics less regularly when they are not experiencing symp-
toms (and are likely to have higher CD4 counts) than when they are feeling sick
(and are likely to have lower CD4 counts). In other words, the probability of
a visit may be correlated with the CD4 count of the patient. As a result, the
number of measurements within a given time period may vary by the value of
those measurements. Furthermore, short-term fluctuations are characteristic of
blood counts and can be quite large. Even though the CD4 counts may follow
some longer-term trend in response to treatment or patient deterioration, the
parameters of this trend are difficult to estimate due to the small number and ir-
regular spacing of measurements. Both issues make it difficult to determine when
a patient’s treatment status has truly changed. The assessment of whether a pa-
tient has progressed to a higher level disease category, and when that progression
occurred, will therefore be, to some extent, subjective.
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This prompts two key questions:
1. Assume that each sampled CD4 measurement taken during check-ups is
a true representation of the underlying blood count and that an above-
threshold measurement indicates that a patient truly has an above-threshold
CD4 count. Given that the patient’s visits (and, hence, timing of blood
counts) are irregular, how can we tell at which timepoint the patient most
likely reached that threshold?
2. Understanding that the previous assumption does not hold in practice, due
to the short-term fluctuation of those counts which mask the underlying
trend, can we model this underlying trend to determine when the patient’s
CD4 counts most likely reached the threshold?
Both of these questions will be addressed in this thesis.
1.1.2 Scope and layout of thesis
This thesis considers the impact of uncertainty in classifications and endpoints
on statistical inference, particularly in survival analysis. Survival analysis is com-
monly used to chart the progression of a patient’s disease or response to treat-
ment, with common endpoints (or time of “failure”) being the onset or regression
of symptoms, exceeding a threshold which moves the subject into a different sta-
tus category, and death. Our aim is to develop extensions to the current survival
analysis tools that incorporate endpoint uncertainty.
In the next section, we introduce the features of survival data and analysis, in-
cluding the survivor and hazard functions for describing endpoint data. Chap-
ter 2 describes Cox regression, a widely used tool for analyzing the effects of
different variables on endpoint times. In Chapter 3 we introduce the idea of
using probability-based weights in Cox regression where there is uncertainty sur-
rounding the timing of endpoints, and weighting schemes which can be used in a
weighted Cox regression are then developed. These schemes are compared using
simulations in Chapter 4 to illustrate their properties and behaviour. Finally, in
Chapter 5 we implement these weighting schemes to analyze comparative rates
of response to treatment among HIV patients, including times to rebound from
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baseline CD4 measurements to higher threshold values among the Western Aus-
tralian HIV (WAHIV) cohort as a result of anti-retroviral therapy. Data is drawn
from the WAHIV study based at Royal Perth Hospital [30]. The thesis concludes
with a discussion of our findings and recommendations for further research.
We aim to develop methods that, while being mathematically sophisticated, are
accessible to the non-statistician. While the problems selected for investigation re-
flect current challenges in biomedical research, the need to incorporate uncertainty
into statistical analyses is not unique to biomedical problems. As such, the tools
developed in this project can be applied to any area where similar analyses are
required, such as time-to-event analyses in econometrics and engineering.
1.2 Features of survival data and survival anal-
ysis
Survival data reflects the time to occurence of a specific event, or “endpoint”,
from a well-defined “time origin”. The time origin for each patient in a study may
be the time at which they were recruited into the study, the time at which they
were first diagnosed with the disease of interest, or the time at which they com-
menced treatment, depending on the objective of the analysis. Since the original
motivation for these methods was the analysis of clinical trial time-to-death data,
they have been termed “survival analyses”; however, as discussed previously, the
endpoint may not be death, and so the times recorded may or may not literally
be survival times [28]. Outside the medical world, survival analysis has been used
in numerous applications, such as time to failure of machine components in in-
dustrial reliability studies, duration of unemployment periods in economics, or
task completion times of subjects in psychological studies [12]. The time origin
for an individual is usually denoted t0. The endpoint for that individual can then
be denoted t, with t falling at some timepoint after t0. Each individual has a
distinct time origin and separate endpoint. Individuals may enter and leave the
study at different times to each other, but the time scale for each person will start
at his or her particular time origin. Figure 1.1 shows this for three individuals
with their times in the study in the top diagram and their times-to-event plotted
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Figure 1.1: Times in the study for three individuals
in the lower diagram.
Three requirements must be met in order for time-to-event to be precisely deter-
mined. Firstly, the time origin must be clearly defined for each individual, which
allows for a time-to-event to be precisely measured and sets a timepoint at which
individuals may be compared on any explanatory variables of interest. A time
origin must be unambiguous, relatively straightforward to determine for each in-
dividual, and subject to as little bias as possible [12]. Seeing as the CD4 counts of
patients in our HIV study exhibit a high degree of short-term fluctuation, making
it difficult to determine the true CD4 counts, using the time at which a patient
presented with a particular CD4 level as the time origin would be highly problem-
atic. Additionally, not all patients would have been observed at the time of the
chosen CD4 level. Initial CD4 level could be a useful explanatory variable, but
date of diagnosis, date of entry to the study, or treatment commencement date
would make for a better time origin. Individuals may enter the study at different
points in calendar time; however as long as this timepoint is well-defined, it is
acceptable as a time origin.
Secondly, there must be a scale to measure the passage of time, the choice of
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which is based on its meaningfulness in the context of the research question [12].
Often this scale is simply real time, using calendar dates, although in non-medical
fields, scales such as system operating time are also common. For our example of
a HIV study, we have chosen months as our timescale, given the chronic nature
of HIV infection and long-term nature of treatment, and that observations are
taken several months to years apart.
Finally, the meaning of the point event which constitutes a “death” or “fail-
ure” must be precisely defined. While in medical work, failure could mean death
(which may or may not be a result of a specific cause), recurrence or remission
of a disease, or similar, in other applications it could mean the first instance of a
quantifiable decline in performance below an acceptable level [12]. In studies of
HIV treatment efficacy, the “failure” event may be defined by the patient’s CD4
count reaching or exceeding a given threshold. When short-term fluctuations in
counts are combined with the irregularity of patient visits, this makes the deter-
mination of endpoints using CD4 counts problematic and subject to a high risk
of error. It is in fulfillment of this third requirement for which the improvements
in this thesis are proposed.
1.2.1 Survival time distribution and censoring
Each individual is monitored, either continuously or at discrete intervals, from
the time they enter the study (their t0) to the time they leave, and the duration
of their time in the study is the single measure of their survival experience. It can
be noted that the calendar time at which they entered the study may have some
influence on their time-to-event, say, if different diagnosis guidelines or treatment
regimens were used at different start times. However, this is normally recognized
in the form of a regression explanatory variable (detailed in later chapters on Cox
and longitudinal regression modelling).
Special characteristics apply to survival data which do not apply in many standard
forms of data analysis. Firstly, the distribution of survival times tends to be posi-
tively skewed. This rules out the use of methods that rely on normally distributed
data, and while it may be possible to apply a transformation to the skewed data,
it is preferable to assume a different distribution for the data [9].
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Secondly, survival data are often censored, meaning that the time-to-event for
an individual cannot be ascertained or was not observed. The time-to-event, t, is
then latent and replaced by the observed time-to-censoring, c, representing the
time that the patient spent in the study [9, 28].
In right-censoring, the most common form of censoring, the observation of an
individual ceases before the endpoint of interest is observed [9]. The censored
survival time then has the property c < t with the event of interest t occurring
in the interval (c,+∞). The research study may have been stopped before the
endpoint event occurred, an individual may have been lost to follow-up, or an
individual may have left the study for a reason unrelated to the occurrence of
the endpoint event. It is worth noting that there could be some difficulty in
determining if the reason for a patient leaving the study is truly unrelated to
the disease or treatment under study [9]. For instance, a patient in the above-
mentioned HIV study may have experienced a fatal fall or other accident. This
seemingly unrelated accident could have been caused by the patient experiencing
migraines or dizziness, both side effects of HIV treatments. If such cases commonly
occurred in a study, this may open another line of investigation comparing the
difference in censored survival times between related and unrelated causes.
On the other hand, left-censoring occurs when the endpoint event for an individual
is known to have occurred before the beginning of observations on the individual.
An example of this would be an individual, who, up until he or she had presented
with AIDS symptoms, was unaware of being HIV-positive. The patient’s true
CD4 count could have dipped below the threshold for an AIDS diagnosis some
time before the observed measurements, making their time-to-event shorter than
what was observed. Left-censoring is much rarer than right-censoring [9].
Interval censoring occurs where the endpoint of interest falls between two known
timepoints, with the actual endpoint time unknown. This type of censoring is most
often seen in studies in which reporting is widely-spaced or irregular [9, 17, 46].
We will not consider interval censoring in this thesis.
The concept of right-censoring can be illustrated easily using some adjustments
to Figure 1.1 above. Suppose that the length of the study is 550 days. During
this time, Individual 1 enters the study and experiences the endpoint event before
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Figure 1.2: Uncensored or right-censored events for three individuals
the end of the study. Individual 2 enters the study after its start but is lost to
follow-up before the study ends, with his or her final observation occurring at
Day 495 at which point he or she was yet to experience the event. Individual
3 also enters the study after its start and reaches the end of the study without
experiencing the endpoint event. As shown in Figure 1.2, Individual 1 will have
an observed endpoint, Individual 2 will have a right-censored endpoint at the
time of last observation, and Individual 3 will have a right-censored endpoint
at the time the study ended. “©” denotes where right-censoring occurs in the
times-to-event.
Random censoring is assumed in the analysis of censored survival times, meaning
that the cause of censoring for an individual must not be related to factors influ-
encing the actual survival time of that individual [9]. Coming back to the HIV
study, a situation in which an HIV drug trial was stopped due to patient deteri-
oration, for example, would be a violation of the random censoring assumption.
The censoring is now based on factors that would have influenced patient survival,
a process known as informative censoring. From here on, whenever censoring is
mentioned in this thesis, it refers specifically to right-censoring.
8
1.2.2 The survivor and hazard functions
The purpose of most survival data analyses is to elucidate any relationships be-
tween recorded characteristics of individuals in a study and their time-to-event,
or survival time. The survivor and hazard functions are the main mechanisms
by which an individual’s probability of “survival” or “death” can be defined and
measured.
The time-to-event, or time-to-death, t of an individual can be treated as the value
of a continuous random variable T which takes any non-negative value and has
the cumulative distribution function [12]
F (t) = P (T ≤ t)
representing the probability that the survival time is less than or equal to some
value t. The probability that an individual survives beyond time t is then given
by the survivor function [45],
S(t) = P (T > t) = 1− F (t) (1.1)
The hazard function represents the rate of death of an individual at time t, given
that they survived up until that time. Unlike the survivor function, which is
a probability, the hazard function is a rate (i.e. the probability of instantaneous
death per unit time). Suppose an individual survived up to time t, so their survival
time is given by T > t. However, the individual dies within a very small, negligible
period of time following t, that is, T ∈ (t, t+ ∆t]. Then the probability of death
sometime between t and t+ ∆t is given by [9, 45]
P (t < T ≤ t+ ∆t|T > t).
The hazard function, or instantaneous death rate, at t is given by
h(t) = lim
∆t→0




P (t < T ≤ t+ ∆t|T > t) = P ((t < T ≤ t+ ∆t) ∩ T > t)
P (T > t)
= P (T ≤ t+ ∆t)− P (T ≤ t)
P (T > t)
= F (t+ ∆t)− F (t)
S(t) ,
so we can derive h(t) as follows:
h(t) = lim
∆t→0














Substituting in (1.1) gives




where log denotes the natural logarithm.
Hence, H(t) = −logS(t) where H(t) =
∫ t
0 h(u) du is known as the cumulative
hazard function, and so [9]
S(t) = e−H(t). (1.2)
Both the survivor function S(t) and the hazard function h(t) can be estimated
from the observed times-to-event. Several parametric forms may be used to model
the survivor and hazard functions, such as the Weibull, exponential, or Gompertz
distributions. However, non-parametric estimators have grown in popularity in
recent decades due to their few assumptions and ease of fit under most conditions,
and here we use one of these, the Kaplan-Meier product limit estimator [24].
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Estimating the survivor function
We begin with a simple discrete-time case, where the time axis is divided into
intervals with endpoints t1, t2, . . . , tk, and where all events are observed so that no
censoring is present. Suppose that we start with n individuals at the time origin t0
and that there are d1, d2, . . . , dk deaths in the intervals (0, t1], (t1, t2], . . . , (tk−1, tk]
respectively [31].
We define the risk set, denoted R(t(i)), as the group of individuals at risk of ex-
periencing the event of interest during the ith time interval, (ti−1, ti], with size
ni = n−
∑i−1
j=1 dj. Let the probability that an individual experiences the event of
interest in the ith interval be denoted pi. Then the number of events in the first
interval, (t0, t1], can be modelled by the binomial distribution d1 ∼ Bin(n, p1).
Likewise, the number of events in the second interval, conditional on d1, is
d2 ∼ Bin(n − d1, p21−p1 ) since the probability of experiencing an event in the
second interval is conditional on not having experienced it in the first interval, so
[24]
P (event in second interval|event not in first interval)
= P (event in second interval ∩ event not in first interval)
P (event not in first interval)
= P (event in second interval)
P (event not in first interval)
= p21− p1
.









Let qi = pi1−∑i−1
j=1 pj
, the probability of an event in the ith interval. Inherent to our
analysis is the assumption that the underlying survival times follow the distribu-











For a non-parametric estimate, an intuitive estimator of qi is di/ni, the empiri-
cal proportion of events for at-risk individuals in the ith interval [31]. Thus the










To incorporate censoring, suppose now that in addition to the discrete-time case
study above, we have ci individuals who are lost to follow-up in the ith interval,
(ti−1, ti]. We assume that losses occur uniformly within each interval, and so the
effective number of individuals at risk over the duration of each interval is taken
to be the average [31]
n′i = ni −
1
2ci










The Kaplan-Meier product limit estimator (PLE)
So far, we have defined event times by the intervals into which they fall. Where
the data follow a continuous time scale and the actual observed and censored time
values are known, using the discrete-time approach ignores valuable information
and can obscure significant patterns or relationships. First presented in a joint
paper by Kaplan and Meier in 1958, the PLE modifies the above approach for
continuous time data.
Where censored times and observed event times are tied, we adopt the convention
of placing the censored times to the right of the observed times [24]. Suppose,
then, that on the time scale above the interval widths are given by ∆t, and as
∆t → 0 the intervals become small enough that each contains only observed
events, only censored times, or neither [31].
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We define the censoring indicator
δj =
 1 if tied observations at time tj are uncensored;0 if censored.









where dj is the number of tied events in interval j.
Only the observed event times contribute to the product, causing the PLE to
change only at these times. Calculating Ŝ(t) for each interval results in a series
of probability estimates which can then be plotted against time. Hence, the sur-
vival function is a step function with discontinuties at the observed event times,
and being undefined after the final interval [24]. Censored survival times do not
themselves result in a “step” but are incorporated into the risk of events at each
step.
The Kaplan-Meier estimator is called the “product limit estimate” because it
takes the limit of the product as the interval widths tend towards zero. Peterson
[33] showed that the PLE is a consistent estimator of the true survivor function.
A simple implementation of the PLE is given by Collett [9] and is outlined in
Appendix A.
Estimating the hazard function
While the survivor function estimate Ŝ(t) is based on the cumulative distribution
function of T , the hazard function ĥ(t) is a derivative of a function that has an
exponential relationship to Ŝ(t), as shown earlier in (1.2), and as such, is a rate
of a probability against time. Using data from the same group of individuals, the
hazard function can be estimated by taking
no. of events at time t
no. of at-risk individuals at time t
and dividing this by a measure of unit time.
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A series of time intervals is constructed in the same way as for the estimate of
the survivor function, starting at the time origin t0 and marking the intervals
in which either observed events or censoring occur. Again, di is the number of
events and ni the number of individuals at risk of an event occurrence in the ith
interval, (ti−1, ti]. The probability of having the event occur for an individual is
then di/ni, and the hazard function for t(i), being a rate of this probability per





The use of the interval length, ti − ti−1, means that (1.3) can only be used to
estimate hazard in finite time intervals. Hence the hazard function is undefined
after the final event time, since the length of the time interval after that point
is not finite [9]. The hazard function, like the survivor function, is also a step
function but is defined as a rate — that of the instantaneous event probability
per unit time in the study, based on the ratio of individuals for whom the event
has occurred to the number of at-risk individuals [9].
In most cases where such data are gathered, event times are not the only infor-
mation sought, and researchers are usually much more concerned with how the
demographic, behavioural, or medical characteristics of the individuals studied
relate to their event times. The Kaplan-Meier method only describes the charac-
teristics of the survivor and hazard functions themselves, and has further tools
allowing us to compare between groups and estimate percentiles. More sophisti-
cated methods are required to investigate the relationships between event times
and other variables, and the most commonly-used method, Cox regression, is
discussed in the next chapter.
Standard errors and confidence intervals for the survivor function








which is known as Greenwood’s formula [9]. The derivation is obtained using the
Taylor series approximation to the variance of a function of a random variable,
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and details are given in Appendix B.
Confidence intervals can be calculated using a complementary log-log transfor-
mation, which transforms the survivor function estimate, a probability bounded
by [0, 1], to one ranging from (−∞,+∞), and gives 100(1−α)% confidence limits
of
Ŝ(t)exp[±zα/2 s.e.{log(−log{Ŝ(t)})}]
where s.e{log(−logŜ(t))} = (logŜ(t))−1[∑kj=1 djnj(nj−dj) ]1/2 [9]. Details on this and
other approaches are given in Appendix B.
Confidence limits for a dataset will need to be calculated for each “step” of the
Kaplan-Meier survivor step function for that dataset. Bands of the confidence lim-
its can then be plotted on a graph of the estimated survivor function, and, when
using one of the above methods, are only valid for intervals of time between events,
with steps or discontinuities occurring at steps of the survivor function.
1.2.3 The log-rank test for comparing survivor func-
tions
Comparison of two groups of time-to-event data may be done using hypothesis
testing. In particular, the log-rank test can be used with high statistical power
when the property of proportional hazards (expanded upon later) can be reason-
ably assumed [9]. Derived by Peto and Peto [34], the log-rank test is conceptually
intuitive in its concept and implementation follows on naturally from the Kaplan-
Meier survivor and hazard functions.
We consider two groups of survival data (Group I and Group II) with r distinct
event times between the two groups, ranked from smallest to largest such that
t1 < t2 < . . . < tr. Let n1i and n2i be the number of at-risk individuals just before
time ti in Group I and Group II respectively. At least one individual experiences
the event of interest at each event time, with the number of events occurring at
time ti in Group I and Group II being d1i and d2i respectively. The total number
of at-risk individuals and the total number who experienced an event at the ith
event time, are then denoted ni and di respectively. The relationships among
these totals are shown in Table 1.1 [9].
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Table 1.1: Events and risks of events before, at and after the ith event time
Group I II Total
Number at risk just before ti n1i n2i ni
Number of events at ti d1i d2i di
Number at risk beyond ti n1i − d1i n2i − d2i ni − di
A test of differences between the survival functions of the groups requires some
measurement of how much the distribution of events in each group differs from
the expected distribution should the survival functions in fact be the same.
Given n1i, n2i, and fixed ni and di at any event time ti, if the survival functions
of the two groups are the same then all individuals between the two groups have
equal probability of being the one to have experienced an event at ti. The values
of d2i and n2i vary only with d1i and n1i respectively, and so we choose d1i as a
random variable. If the survival functions are the same, then d1i is distributed



















n2i (ni − 1)
.
We then compare the number of individuals in Group 1 experiencing the event at
each death time to the expected number [9], summing the difference between the











This is a sum of conditionally uncorrelated random variables, which by the central
limit theorem is approximately normal for large sample sizes, with mean 0 (since









with a significant p-value indicating that the survivor functions differ between the
two groups [9]. When testing for the significance of a single factor, the log-rank
test for two groups is equivalent to the score test for Cox regression.
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Chapter 2
The Cox Regression Models for
Time-to-Event Analyses
Having described the common means by which times-to-event are displayed and
compared, we now turn our attention to regression models which allow us to in-
vestigate variables that predict when events may occur. The proportional hazards
models, or Cox regression models, provide an approach to explore the relation-
ship between event times and explanatory variables measured on individuals in a
study [10]. They are based on the Lehmann family of hazard models, which are
of the form
h(t|ρ) = ρh0(t)
where ρ is some parameter with a multiplicative effect on the baseline hazard
function h0(t) [12].
The simplest of the Cox models involves only values of explanatory variables
measured at the time origin t0 of a study. Since the main interest in such studies
is usually the probability of event occurrence, the form of the hazard function
and variables which may influence the hazard become the main focus in Cox
regression.
Cox regression analysis serves two broad purposes [9]:
1. To determine the combination of explanatory variables which affect the
hazard function of an individual or most differentiate the hazard functions
of groups of individuals.
18
2. To obtain an estimate of the underlying baseline hazard function. From this
we can obtain and compare survivor functions, estimates of the median and
percentile survival times, and make predictions about the survival of future
individuals.
2.1 Proportionality of hazards assumption
Proportional hazards regression analysis as proposed by Cox [12] is semi-
parametric, not reliant on any particular distribution for the survival times, and
depends on the single key assumption of proportional hazards. Suppose that we
are comparing the survival of a group of n individuals in a clinical trial, where
patients undergoing a new treatment are observed and their survival compared to
the survival and hazard on a different, standard treatment. The hazard of death
at time t per unit time for the ith individual on the new treatment is denoted
hi(t), i = 1, . . . , n, while the hazard for the standard treatment is denoted h0(t)
and referred to as the baseline hazard [9].
The proportional hazards assumption states that there is a proportional, multi-
plicative relationship between the hazards which can be expressed as
hi(t) = ψh0(t), (2.1)
where the survival time t is non-negative, and the relative hazard (or hazard
ratio) ψ is both positive and constant with respect to t [12]. Any covariates or
explanatory variables incorporated into this model, therefore, are assumed to have
a multiplicative effect on the baseline hazard.
Graphically, proportional hazards implies that the true survivor functions corre-
sponding to hi(t) and h0(t) do not cross at any t [9]. Cox proposed that, if this
assumption holds, a procedure for determining the influence of explanatory vari-
ables on the baseline hazard can be carried out without knowledge of the form of
the baseline hazard itself.
Since ψ > 0 we can write ψ = exp(β) such that β = log ψ. This transforms the
range of ψ to (−∞,+∞). We then note that if ψ < 1, then β < 0, and so a
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negative β value clearly indicates a lower hazard and better survival [9].
2.2 The general Cox regression model
Now covariates can be incorporated into the form of the proportional hazards
model. For example, an indicator variable X could be set up such that
X =
 0, if the individual is on the standard treatment;1, if the individual is on the new treatment.
The value of X for each individual i = 1, . . . , n is denoted xi, and so
hi(t) = exp(βxi)h0(t)
=
 exp(β)h0(t) if the individual is on the new treatment;h0(t) if the individual is on the standard treatment.
This provides the simplest form of the model, where the type of treatment, a
binary covariate, is the only variable considered to potentially explain differences
in survival. There is much room for extension of this model to include covariates
or a mixture of factors and continuous covariates. In a situation where the hazard
function is thought to depend on p explanatory variables X1, . . . , Xp recorded at
the time origin for each individual i = 1, . . . , n in the study, each explanatory
variable is recorded at a particular value for each individual and can be set in a
vector xi = (x1i, . . . , xpi)′ [10].
Extending the definition of the baseline hazard, now let the baseline hazard be
the hazard function h0(t) for an individual for whom x = 0. The hazard ratio
ψ(xi) is now a function of the explanatory variable values, and so
hi(t) = ψ(xi)h0(t)
is now the hazard function for individual i, which multiplies the baseline hazard
by some function of the explanatory variable values for that individual.
However, ψ = exp(β) as written before, and so we could assume that for a
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multivariate model,
hi(t) = exp(β′xi)h0(t) (2.2)
where β = (β1, β2, . . . , βp)′, the coefficients for each of p explanatory vari-
ables.
Rearranging this and applying the natural logarithm to both sides of the equation
creates a logarithmic function of the ratio between the hazard of individual i and
the baseline hazard equal to a linear combination of the explanatory variables,
known as the risk score or prognostic index for the ith individual. Hence the linear






= β′xi = β1x1i + β2x2i + . . .+ βpxpi.
The linear combination of covariates which make up the log hazard ratio, β′xi, is
known as the linear component of the model, and may incorporate variates, fac-
tors, and possibly interactions of the two in a manner similar to linear regression.
The assumption of proportional hazards requires that the covariates, measured
on each individual at baseline, are assumed to be time-invariant.
2.3 Estimating the model parameters
Fitting the proportional hazards model requires the estimation of β, by maxi-
mization of a partial likelihood. In some cases it may be useful to postulate a
parametric form for the baseline hazard function h0(t), but in assessing the in-
fluence of explanatory variables on the hazard it is not necessary. Here we will
concentrate on estimation of the parameters, while estimation of the baseline
function is covered well by Collett [9].
2.3.1 Maximization of the Cox partial likelihood
The maximum likelihood estimator (MLE) of the parameter vector is the vector
of values that is most likely given the data observed. It is widely used as it
is asymptotically efficient as well as conceptually intuitive. At its core, it is a
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formalization of the question, “Which parameter values for this model would
make it most likely to result in getting the data I see?” [38]
We begin with the definition of a likelihood of the parameter vector for individual
i, denoted L(β|xi). This is a function of how likely it is that β takes a particular
vector of values, based on data for the ith individual. Returning to our example,
suppose that out of the event times recorded for n individuals, we have r distinct
event times and n− r right-censored event times, and that no two individuals ex-
perienced any events simultaneously, whether censored or uncensored. (Situations
where there are ties in the event times are dealt with in a later section.) These
event times tj, j = 1, . . . , r, are ranked in order such that t1 < t2 < . . . < tr. In
the previous chapter, we defined nj to be the number of at-risk individuals just
before tj. We now denote the set of these individuals as the risk set, R(tj).
Cox claims that where h0(t) is not specified, intervals within which no event times
occur convey no information about the effect of the explanatory variables on the
baseline hazard h0(t), our information being drawn solely from the relative rank
order of the event times. We then adopt an arbitrary form for h0(t) where h0(t) =
0 during the intervals where no events occur. Hence the likelihood of having the
ith individual experience the event at tj, out of all the possible individuals at risk
at that time, is given by
P (ith individual has an event at tj | an event has occurred at tj).
Applying Bayes’ Rule, this is equivalent to
P (individual with variables xj has an event at tj)
P (one death at tj)
(2.3)
where xj denotes the vector of explanatory variables for the individual who ex-
periences an event at tj. The numerator of (2.3) is equivalent to the hazard of an
event at tj, or hi(tj). The denominator is equivalent to the probability of having
any of the individuals in the risk set for tj experience an event at tj, which comes
from summing the individual event probabilities over the risk set, that is, over
every individual l in R(tj).
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This is the marginal probability for the event of interest occurring for the ith indi-
vidual at tj, as observed. Due to the assumed independence of event experiences
between individuals observed, the joint probability of obtaining a particular β
given our particular set of observations over all event times t1, . . . , tr is the prod-








As with the product limit estimator discussed in Section 1.2.2, although censored
times are not included in the ranked event times, censored individuals must be
included in the risk set just before the times of each observed event. In order to
incorporate these individuals into the risk set, we now let the data consist of event
times t1, . . . , tn for all individuals in the study whether censored or uncensored,
and introduce the censoring indicator [8]
δi =
 0 if the event time ti is right-censored;1 otherwise.










Finding the MLE, as its name suggests, consists of finding β̂, the estimate for β
which maximizes the likelihood function L(β). This may be done computationally
using an iterative root-finding method such as Newton-Raphson. It is usually
more computationally efficient to maximize the log-likelihood, L(β), by setting
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to zero, and solving for β̂ [9, 10].
2.3.2 Asymptotic properties of the partial likelihood
The proportional hazards model, by definition, assumes no fixed distribution for
the time-to-event data (values taken by the continuous random variable T ), and
relies only on information regarding the rank order of event times and the number
of events at each event time [28]. Also, we often do not have information on the
event experience of an individual with covariates xi = 0, and so the form of h0(t)
remains unknown. Cox’s likelihood, therefore, is a partial likelihood function,
based on the transformation of continuous time data to count data, intentionally
ignoring the durations between events, and specifically designed to eliminate the
need for any information about h0(t) [11, 28].
Efron later confirmed Cox’s original conjecture that L(β) shares the asymptotic
properties of a full likelihood [15]. The MLE β̂ is a consistent estimator of β,
having the asymptotic expected value of β. Also, for situations in which the
proportional hazards assumption is reasonable, such as where the covariates x
do not vary with time, the Cox likelihood has full asymptotic efficiency, and
the resulting parameter vector estimate has a covariance matrix asymptotically
equivalent to the inverse of the p× p Observed Fisher Information matrix,






with censoring having little effect on efficiency unless a large proportion of indi-
viduals in the sample have the same censoring time [15, 16]. Efficiency increases
with sample size [22]. Standard errors of the parameter estimates are then given
by the square roots of the diagonal elements of V(β̂).
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2.3.3 Score, Wald, and likelihood ratio tests
The score, Wald and likelihood ratio tests can be used to test the significance of
any of the covariates, and follow naturally from the maximization procedure for
the Cox partial likelihood [45].
The score test statistic is given by U′(0)I−1(0)U(0), the likelihood ratio test
statistic is given by 2[L(β̂) − L(0)], and the Wald test statistic is given by
(β̂)′ I(β̂)(β̂). These test statistics are similar to those applied to generalized
linear models [1]. Each test has an asymptotic chi-squared null distribution with
degrees of freedom equal to p, the number of parameters being tested. Where
only a single categorical parameter is being tested, the score test is equivalent to
the log-rank test from Section 1.2.3.
2.3.4 Interpreting the model parameters
Model parameters for the Cox regression model can be interpreted in a similar
way to those of a logistic regression model since the linear component of the
model is equivalent to the log-hazard ratio in a Cox model and a log-odds ratio
in a logistic regression model. By the proportional hazards assumption, each
variable is interpreted as having a multiplicative effect on the baseline hazard. It
is important to interpret the influence of each term in the presence of all the other
terms in the model, given that the individual coefficients are not independent of
one another and terms may be correlated [9].
2.3.5 Incorporating tied event times into the
likelihood
So far we have assumed that only one individual experiences the event of interest
at each event time. However, simultaneous events can occur, particularly with the
rounding of times [9]. These ties are incorporated into the analysis by modifying
the original Cox partial likelihood. We retain the original interpretation of xj,
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and dj, the number of events at time tj, but introduce a new vector
sj = {shj} = [s1j, . . . , spj]′ = [
dj∑
k=1









is the sum of xj’s over all dj individuals who experienced an event at tj, for each
of p explanatory variables.
Three proposed modifications to the likelihood function are outlined below. Cen-
sored individuals can be readily incorporated into each of these likelihoods simply
by inclusion in the risk sets of the event times prior to their respective censored
times, since they do not contribute an individual component to the Cox likelihood
in (2.5).
1. Breslow’s likelihood [4] modifies the numerator of (2.4) to include the xi’s
from all individuals experiencing an event at tj, and assumes that tied events
occur distinctly and sequentially. The denominator sums the probabilities of
all possible sequences of events, and provides reliable results if the number






2. Efron’s likelihood [15] is theoretically more accurate than Breslow’s, al-
though in practice if the number of ties is small relative to the size of the
risk set, both the Breslow and Efron likelihoods tend to give similar re-
sults [9]. It makes the greatest modification to Cox’s original likelihood and












3. Cox’s likelihood modifies the numerator of 2.4 to include xi observations
from all individuals experiencing an event at tj, and the sum in the denom-
inator is taken over all possible combinations of dj individuals that can be
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Instead of the proportional hazards model for continuous time in (2.2), this







which allows for a large number of ties relative to the risk set. When the
natural logarithm is applied to both sides, the linear component β′xi has
an additive relationship between the log odds of the hazard for individual












2.4 Assessing model fit
After fitting a Cox model and estimating the parameter values, we require some
method of determining how well the model fits the data, and whether variables
that have a statistically significant influence on the log-hazard ratio can be iden-
tified. Small p-values under the score, Wald or likelihood ratio tests for an esti-
mate provide evidence that a term has a significant influence on the log-hazard
ratio.
Difficulty exists in interpreting and applying the results of such tests, however.
Tests for individual parameters are carried out conditional on the model; hence
they indicate whether a term is significant in the presence of other terms [9]. The
coefficient estimates are not independent of each other, and the coefficient of each
term could change when any non-significant term is removed [9]. If only one term
in the model is found to be non-significant, it may be removed from the model
without adversely affecting its explanatory power. However, if more than one term
is found to be non-significant, this does not mean that all the non-significant terms
can be removed. Due to this complication, it is preferable to carry out tests of
comparison between models including certain terms and models excluding them,
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which use likelihood ratio tests instead of Wald tests.
Assessing the goodness of fit
Following the fitting of the Cox model to a dataset, we need to assess how well
the model fits the data. Several types of residuals can be used to assess a Cox
model, including:
• Martingale residuals to assess the functional form of a covariate,
• Deviance residuals to identify poorly-predicted points,
• Dfbeta or delta-beta residuals to identify highly influential covariate values,
and
• Schoenfeld residuals to assess the assumption of proportional hazards.
As we will not be using these residuals for data analysis in this thesis, we avoid
going into details here. However, a thorough treatment of the theory behind these




Weighted Cox Modelling for
Uncertain Endpoints
We have discussed in Chapter 2 current practices in general Cox or proportional
hazards modelling (PHM), including the treatment of censoring and ties, and
the adjustments to the likelihood that have been developed to address these. A
further challenge relates to endpoint uncertainty. Here, observations are made in
time which suggest that the endpoint event has occurred, but, for reasons such
as inherent variability in the measurements, we cannot be sure of the exact time
of its occurrence or, indeed, whether the endpoint has truly occurred. Returning
to our motivating HIV example, the event of interest is defined as having oc-
curred if the patient’s CD4 count has reached a certain threshold, say, 500 cells
per mm3 following treatment, and the patient then moves from the category of
“unsuccessful” to “successful” in treatment outcome. However, the experimental
and natural variability of CD4 measurements means that a single above-threshold
measurement cannot be taken to indicate that a patient’s underlying CD4 count
has truly reached the threshold and hence, that the endpoint event has indeed
occurred.
In recognition of this, time-to-threshold studies have often adopted practices of
taking the first of two consecutive above-threshold measurements as the indi-
cator of the endpoint [41, 42]. The second such measurement, therefore, serves
as a confirmation that the first above-threshold measurement was in fact a true
event. However in reality, the patient’s true CD4 count could have reached the
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threshold at any time during the study or may not have reached it at all, and the
nature and variability in CD4 counts either masked this or falsely suggested an
event occurrence. Some studies have taken the second of two consecutive above-
threshold counts as the endpoint, however any variation on this practice carries
similar uncertainty regarding the true endpoint.
In this chapter we explore the incorporation of this uncertainty into the Cox
regression model through the use of probability weightings and discuss the appli-
cability of a specific weighted Cox likelihood to our problem of interest. Following
this, we propose a novel use of weights in a Cox model to “split” observations
on individuals, discuss related assumptions and implications, and describe two
weighting schemes developed for use with Cox modelling.
3.1 Binder’s weighted Cox model
Weights are commonly used in regression modelling to represent differential sam-
pling probabilities for complex samples. It is in this context that Binder [3] pro-
posed an adaptation of Cox’s likelihood based on the generalized technique from
Horvitz and Thompson [20], and several others have used and adapted his ap-
proach for stratified surveys, longitudinal surveys, and complex survey models
[5, 23, 27, 32]. This approach incorporates weights proportional to the inverse
sampling probability of an individual in a modified score function such that the
total weighting assigned to a demographic group in the sample corresponds to
their representation in the population of interest [6].
Sampled individuals i = 1, . . . , n from a population of size N have ranked death
times t1 < . . . < tn, and xi is the vector of covariates for an individual with ranked
death time ti [3]. The Binder score function is based on a generalization of the
Cox likelihood which reduces the dataset purely to a set of event times {ti}ni=1
which may or may not be censored, with uncensored and censored observations
denoted by δi = 1 and δi = 0, respectively [9]. Sampling weights {wi}ni=1 are
introduced to adjust the contribution of an individual’s result to the sample total
with the restriction ∑wi = 1 when scaled by n. Also used is an indicator Yi(t),
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which has the value
Yi(t) =
 1 if the individual i has not experienced the event before time t;0 otherwise.
Since a value of Yi(t) = 1 indicates that an individual has not yet experienced the
event and is hence at risk of the event at time t, summing the terms multiplied
by Yi(t) over i is equivalent to summing the terms over the risk set R(ti) in the
original Cox likelihood in (2.4). We shall refer to this as the “risk indicator”.
3.1.1 Parameter estimation
















































Using the above notation to replace membership of the risk set l ∈ R(ti) with the
risk indicator Yi(t) for each member i, the Cox score function for censored data















Hence, Binder’s score function in (3.1) is essentially a weighted version of the Cox
score function in (2.6), with the weight wi assigned to individual i’s contribution
to the risk set and the overall score.
While the Cox likelihood is designed for inference on a population assuming ran-
dom sampling, Binder’s likelihood allows inference on a finite population by incor-
porating weights that scale the sample up to population size and demographics.
Hence the Binder likelihood is a pseudolikelihood, and its corresponding esti-
mator β̂ is a pseudo-maximum likelihood estimator (PMLE), in contrast to the
maximum likelihood estimator (MLE) that we derive from unweighted sample
data.
Like all Cox models and their modifications discussed in these chapters, parame-
ter estimation here may be done iteratively using Newton-Raphson. Binder argues
that β̂ is consistent and approximately normally distributed, and that it is most
useful when the proportionality of hazards can be reasonably assumed [3]. He
also showed by simulations that, although β̂ is not an unbiased estimator of β,
for non-representative samples the bias of weighted estimates is small compared
to unweighted estimates [3]. Lin [27] provides a formal justification of Binder’s
method, showing that β̂ is a consistent estimator of β and interpreting the “ap-
proximate” normality for β̂ to mean asymptotic normality.
Variance estimation for Binder’s β̂
Binder [3] presents a Taylor linearization estimate of the asymptotic covariance
matrix for β̂ which was justified in an earlier work [2], given by
V(β̂) = I−1 V[Û(β)] I−1,








and ui(β̂) is estimated by
ûi(β̂) = δi

















For this estimated covariance matrix it is assumed that the sample size n, while
being large, is small relative to the population size N . The estimator β̂ is also
assumed to be approximately normally distributed. Small to moderate sample
sizes, as well as heavy censoring, can affect the accuracy of statistical procedures
based on the normal approximation, and the use of more robust methods such as
the jackknife estimation procedure (discussed later in Section 3.4.4) can produce
more accurate variance estimates in these situations [45].
3.1.2 Other uses of weighting in Cox models
An alternative use of weights in Cox modelling is to attach them to hazard ra-
tios for different time periods. This is done in cases where the effect of at least
one covariate on the hazard ratio changes over time, violating the assumption of
proportional hazards and causing the average hazard ratio for the model to be
incorrectly estimated [43]. These weights could reflect the proportion of individ-
uals for which the hazard ratio is applicable over a particular interval, in which
case the weight assigned w(t) would be the survivor function S(t) [43]. In the case
of our HIV study, we continue to assume proportional hazards in the absence of
evidence to the contrary, making weighting of time intervals inappropriate.
Pugh, Robins, Lipsitz and Harrington [39] proposed a series of reweighted score
equations for use in cases of missing covariate data, with subject-specific weights
inversely proportional to the probability of having complete data on that subject.
These probabilities are estimated from the data using logistic or probit regression
and may depend on the other covariates. They showed that such modified Cox
parameter estimates are approximately unbiased for large sample sizes [39]. Kim
and Skinner [25] also proposed two approaches to subject-specific weighting when
sampling is done conditional on the covariate values (informative sampling), using
33
weights calculated through the fitting of auxiliary weight models. Both papers
present approaches to weighting for the Cox analysis that depend on the fitting
of an auxiliary model to derive the weights, and we explore this idea later on in
one of our proposed weighting schemes.
3.1.3 Applicability of Binder’s model to our problem of
interest
A key issue arises when applying current weighted Cox models to our HIV data.
Survey-style weighting adjusts the contribution to the likelihood of each individ-
ual assuming that their endpoints are well defined, whereas our problem specif-
ically addresses uncertainty surrounding identification of the endpoint, or event
time. Our uncertainty problem requires that probabilities be assigned to obser-
vation timepoints within each individual’s record to capture the uncertainty in
each individual’s endpoint measurement, instead of having weights that differ be-
tween individuals. We propose using a system where weights are assigned to more
than one timepoint on an individual to represent probabilities of observed CD4
counts exceeding a specified threshold and consequently being indicative of true
event times. In the remainder of this section we explore the use of probabilities of
observing the endpoint as weights for an individual’s observations, and how this
can be implemented in our study of interest.
Suppose we have a study in which physiological measurements are taken during
a series of visits (possibly at irregularly-spaced timepoints) to determine the end-
point status of an individual at each visit time. We specifically consider the case
where the endpoint is defined as reaching or exceeding a threshold measurement.
Each individual i has mi incrementally ranked visit times, starting at t0, the visit
time at which they entered the study, and extending to tmi−1, the last known
visit time. For each visit time, a measurement is taken on that individual that
either reaches or does not reach the threshold, and we expect that at every visit
time there is some probability that the individual truly has reached the threshold.
If the measurements taken lie far beneath the threshold, we would expect that
probability to be very small, perhaps close to zero, while measurements close to
or higher than the threshold would carry larger probabilities. For an individual i
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with mi ranked visit times, wij represents some weight within [0, 1] based on the
probability of the true underlying measurement of the individual having reached
the threshold at tj, j = 0, 1, . . . ,mi− 1. Figure 3.1 illustrates this for individual i
with 5 ranked visit times, where each visit time has an attached weight wij.
Figure 3.1: Weighting endpoint observations on an individual
We assign a censoring indicator to each visit time similar to the one defined in
Section 2.3.1 for censoring individuals. This takes the value
δij =
 1 if the visit produces a non-censored observation for that individual;0 otherwise.
Each visit time at which a CD4 measurement is observed is assigned both a
weight wij and the censoring indicator δij = 1. Calculation of the probabilities
and their relation to subsequent weights is based on a weighting scheme (some
possible schemes are described later). Since the total weight on an individual
must equal 1, the weighting scheme used must satisfy the condition ∑mi−1j=0 wij ≤
1. Any weight left over following assignment of the {wij} to each observation
corresponds to the probability that the individual’s CD4 measurement did not
reach the threshold during the study time, and is assigned to a duplicate of the
last visit time with a censoring indicator of 0. Our approach, therefore, involves
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splitting each individual into a series of pseudo-individuals corresponding to his or
her observations, and assigning a weight and censoring indicator to each pseudo-
individual, as is done with whole individuals in survey-style weighting.
The main challenge of this approach is to identify an appropriate system of
weights for the observations on each individual in the sample. As each weight is
based on the probability of an observation being the endpoint for that individual,
the ideal system would reflect how these probabilities change as an individual’s
observations move closer to the threshold from below, and their fluctuations after
reaching the threshold. In the remainder of this thesis, we will discuss, implement
and compare three different weighting schemes for the observations, which have
been named as befitting their descriptions:
1. First-of-two unweighted (FOT U/W) scheme,
2. First-of-two weighting (FOTW), and
3. Longitudinal conditional probability weighting (LCPW).
3.2 The First-of-Two Unweighted (FOT U/W)
Scheme
The FOT U/W scheme is based on a common practice in survival analysis of HIV
and other studies, where the endpoint for an individual in the study (indicating,
say, successful response to treatment) is determined to have occurred at the time
of the first of two consecutive above-threshold measurements [7, 41]. The guiding
principle is to take only the first of two consecutive above-threshold observations
(which we also call an “above-threshold consecutive pair”) to be the recorded
endpoint, and ignore all other observations on that individual. The following two
scenarios explain this clearly.
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3.2.1 Scenarios in the FOT U/W scheme
Scenario 1: Two consecutive above-threshold observations
Scenario 1 consists of an individual having two consecutive above-threshold ob-
servations occurring at some point during the study. In this case, the first obser-
vation from the first consecutive pair of above-threshold measurements would be
considered the endpoint, receiving a censoring indicator of 1. The individual is
considered to have reached the endpoint at this time, and any other observations
on them can be excluded from analysis, as they have no bearing on the risk set
at any time.
Scenario 2: No consecutive above-threshold observations
Scenario 2 consists of the case in which an individual has no consecutive above-
threshold observations. In such a case, the individual would be considered lost
to follow-up at their last observation time, and their last observation would be
recorded as a censored timepoint for inclusion in Cox analysis. All other obser-
vations on this individual are excluded from analysis.
3.2.2 Context and comparisons
The practice of taking the first of two consecutive above-threshold observations
on an individual to be the recorded endpoint with no differential weighting is
relatively easy to apply. It produces a single recorded “event” for each individual,
censored or otherwise, to be used in product limit estimates of the survivor func-
tion, hazard function and Cox regression. Also, it is fairly intuitive — a single
above-threshold observation could well be due to measurement variation or error,
so waiting for a second above-threshold observation to confirm that the endpoint
has actually occurred is prudent.
However, since a non-censored endpoint is only recorded if two above-threshold
measurements are observed (Scenario 1), a single above-threshold measurement
would not be considered as an endpoint observation at all, despite the possibility
that the individual’s underlying biomarker measurement could have reached the
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threshold at that point. This is of particular concern in cases where that single
above-threshold measurement occurs at the point of censoring, since without
subsequent measurements on that individual, there is added ambiguity about
whether that above-threshold measurement is a first-of-two or not. This brings
us to the first-of-two weighting (FOTW) scheme, which uses weights to deal with
single above-threshold measurements at the censoring timepoint.
3.3 The First-of-Two Weighting (FOTW)
Scheme
The FOTW scheme is based on the common first-of-two unweighted practice, as
outlined previously, but adds the use of weights to account for the uncertainty in
whether or not a single above-threshold observation at the censoring timepoint
could be a first-of-two observation. This is a simple first step in incorporating
uncertainty into the first-of-two methods and can be applied with the same ease
by researchers who prefer to use a first-of-three approach.
We return to the notation and study setup in Section 3.1.3, where each individual
i has mi visit times, and wij represents a weight based on the probability of the
individual’s true underlying biomarker measurement having reached threshold at
time tj. Suppose that we impose a restriction on the {wij}, assigning non-zero
weights only to specific {wij} which correspond to measurements at or above the
threshold, or at the point of censoring if an individual leaves the study prior to
reaching the endpoint. Now, we make j = 1, . . . , ni the rank indices for those
measurements on individual i which reach or exceed the threshold, with weights
{wij}. The weighting scheme must include a method for dealing with any pos-
sible scenario that may occur in the direction of an individual’s measurements.
We make several assumptions relating to how this scheme deals with particular
scenarios, which will be detailed as we examine the individual scenarios. In every
case, the total weight for each individual equals 1. Below we revisit the scenarios
that we described for the FOT U/W scheme, detailing how they would be dealt
with in the FOTW scheme.
38
3.3.1 Scenarios in the FOTW scheme
Scenario 1: Two consecutive above-threshold observations
Scenario 1 describes an individual having two consecutive above-threshold obser-
vations occurring at some point during the study. In this case, the first observation
from the first consecutive pair of above-threshold measurements would be con-
sidered the endpoint, receiving a weight of wij = 1 and the censoring indicator
δij = 1. The individual is considered to have reached the endpoint at this time,
and any subsequent observations on them can be excluded from analysis. Also,
any other observations on this individual without a weight or censoring value can
be excluded from analysis, as they have no bearing on the risk set at any time.
Figure 3.2 shows this graphically.
Figure 3.2: Weighting for two consecutive above-threshold observations
Scenario 2: No consecutive above-threshold observations
In view of the limitations of the FOT U/W scheme regarding the ambiguity
surrounding an individual’s final observation, we can split this scenario into
two:
1. Last observation below threshold (Scenario 2.1), and
2. Last observation above threshold (Scenario 2.2).
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In Scenario 2.1, the individual has no consecutive above-threshold observations,
and their final observation is below the threshold. In such a case, the last obser-
vation would be assigned a weight of wij = 1 and a censoring value of δij = 0,
as illustrated in Figure 3.3. Even though this individual has a weight of zero,
their censored timepoint is still included in earlier risk sets and, hence, must be
included in the analysis. All other observations on this individual are excluded
from analysis. Essentially, the first-of-two unweighted practice stops here, as it
treats all possibilities within Scenario 2 in this way. It is in the inclusion of Sce-
nario 2.2 that the FOTW approach goes one step further.
Figure 3.3: Weighting for no consecutive above-threshold observations, with last
observation below threshold
In Scenario 2.2, an individual has no consecutive above-threshold measurements,
but has an above-threshold observation occurring at the time of censoring, with
no subsequent observations. It is in this scenario where the advantage of weight-
ing observations can be readily seen, since by common practice this observation
would have been considered completely censored. Our FOTW scheme considers
the possibility that this observation could indeed be a first-of-two measurement
and that the individual could have reached the endpoint at this time. Assume
that the probability of this is 0.5. We would assign the values wij = 0.5 and
δij = 1 to this timepoint, and the remaining weight of 0.5 and censoring indicator
of 0 to a duplicate visit at this timepoint, as shown in Figure 3.4.
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Figure 3.4: Weighting for no consecutive above-threshold observations, with last
observation above threshold
This splits the individual into two pseudo-individuals, each with a weight of 0.5
corresponding to one of the two possibilities – either the last above-threshold
observation is the first of an above-threshold consecutive pair and should not be
censored, or it is not the first-of-two and should be censored. The FOTW scheme
takes both these possibilities into account. Both of these weighted observations
will be included in the relevant risk sets and so are included in the analysis, while
all other observations on this individual can be excluded from the analysis.
In this scenario, we make the assumption that the probability of an observation
at a particular timepoint being above threshold is not dependent on observations
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from that individual at past timepoints.
3.3.2 Context and comparisons
The FOTW scheme adds a layer of flexibility to the FOT U/W scheme through
its use of weights to split observations on an individual into “sub”- or “pseudo-
observations”. The impact that the FOTW scheme would have on parameter
estimates calculated under the FOT U/W scheme would depend on the num-
ber of Scenario 2.2 cases relative to the number of individuals in the study.
Although we have applied this weighting only to the ambiguity surrounding a
final above-threshold measurement in the absence of earlier above-threshold con-
secutive pairs, more complex weighting systems could be explored (which are
beyond the scope of this thesis) to weight other above-threshold observations as
well.
The main limitation of the FOTW scheme is that even though we have accounted
for some uncertainty in Scenario 2.2 by weighting the single above-threshold point,
we do not really know if the weight of 0.5 that we have assigned is accurate. In
reality, the probability of the single above-threshold point being a “first-of-two”
point would be influenced by how close previous below-threshold measurements
are to the threshold. A key, but possibly limiting feature of time-to-event analysis
is the use of only one observation per individual (or weighted “pseudo-individual”)
as the endpoint without considering previous measurements. Given the number
of observations we actually have per individual, taking them into account in
some way could be highly informative. For this, we look beyond survival analysis
to longitudinal analysis, which allows for the modelling of measurements over
time. The next weighting scheme, longitudinal conditional probability weighting
(LCPW), has been developed for this purpose.
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3.4 The Longitudinal Conditional Probability
Weighting (LCPW) Scheme
The LCPW scheme incorporates information from all observations on an indi-
vidual in the Cox analysis by applying weights to every visit time, based on
the probability of each timepoint being the true endpoint. The weighted visit
times are then included in Binder’s weighted Cox analysis. The probabilities on
which the weights are based are calculated using an estimate of within-individual
variability from a longitudinal mixed effects model (LMEM). Hence the LCPW
scheme combines the robustness and flexibility of longitudinal modelling with the
applicability of the Cox regression tools to endpoint problems. Unlike the FOTW
scheme, no distinct scenarios are identified, as the LCPW scheme uses the same
method to assign weights to observations for every individual in the study.
Suppose our study consists of n individuals, each individual i having mi obser-
vations taken at different timepoints beginning at his or her time origin t0 and
ending at his or her final visit time tmi−1. Let yij denote the CD4 measurement
taken on individual i at timepoint tj, with the yij being observations on the
underlying trend to the individual’s CD4 measurements. The variability of the
individual’s observed CD4 measurements about his or her underlying trend can
be quantified by some estimate of standard deviation σ̂ (we have chosen to use
the residual standard deviation from an LMEM fitted to measurements from all
individuals in the study, which we explain later). We picture each observation
yij as being the mean of its own normal distribution with standard deviation
σ̂. Using this distribution, we can obtain a measure of the probability that the
individual’s true biomarker measurement has actually reached the threshold yT
at timepoint tj, given by
Pij = P (yij ≥ yT )
= P (Z ≥ yT − yij
σ̂
). (3.2)
(Note that in a Bayesian context Pij estimates the posterior probability that
the mean response, or true biomarker measurement, for individual i exceeds the
threshold yT at timepoint tj, given the observation yij and assuming an improper
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uniform prior for the mean response.)
The probability at tj above is calculated as though it is distinct from and inde-
pendent of any other observations on individual i. However, since observations on
the same individual are not truly independent, and only one threshold crossing
can occur for each individual, the calculated probabilities are actually only con-
ditionally independent. That is, the probability of the true underlying biomarker
measurement having reached threshold at each time is taken conditional on having
not previously reached the threshold. (If the individual was considered to have
reached the threshold at an earlier timepoint, we would have no need for the
probability at tj.) Hence, each probability Pij is really a conditional probability,
expressed as
Pij = P (reached threshold at tj|did not reach threshold before tj)
for individual i.
The weight on each observation is then the joint probability that the individual’s
true biomarker measurement reached threshold at timepoint tj and not at any
of the previous timepoints. The first observation on individual i taken at t0,
therefore, is simply weighted wi0 = Pi0. Subsequent weights for observations at
t1 and onwards are then given by the joint probability
wij = P (reached threshold at tj and not at a visit time before tj)
= P (reached threshold at tj|did not reach threshold at a visit time before tj)×
P (did not reach threshold at a visit time before tj)
= Pij × P (did not reach threshold at tj−1)× . . .
× P (did not reach threshold at t1)
× P (did not reach threshold at t0)





Each observation receives a censoring indicator of δij = 1. After weights are
assigned to all the observations, there will be a leftover weight corresponding to
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the probability that the individual has not reached the threshold by the final
timepoint and should actually be censored at that point. A duplicate observation
is then created for the final timepoint, with the remaining weighting being 1 −∑mi−1
j=0 wij, and the censoring indicator being 0.
Figure 3.5 shows this weighting scheme being applied to 6 observations on indi-
vidual i. The shaded areas represent the area under the Normal(yij, σ̂2) curve
above the threshold yT , corresponding to the conditional probabilities {Pij} for
each timepoint tj. The weights {wij} corresponding to the joint probabilities are
given below the graph along with their censoring indicators {δij} for the observed
and duplicate timepoints.
Figure 3.5: Weighting for single non-consecutive above-threshold observations
3.4.1 Longitudinal mixed effects modelling
We have chosen to use longitudinal mixed effects modelling (LMEM) to estimate
the standard deviation σ̂ of the normal distribution assumed for an individual’s
true biomarker measurement, or mean response, about the observed biomarker
measurement yij, as it allows for the modelling of the underlying biomarker trend
using the series of observed measurements. A comprehensive guide to the theory
and methods for fitting an LMEM can be found in Pinheiro and Bates [37]. Here
we give the details that relate directly to its use in the LCPW scheme, and provide
an overview of the theory and methods in Appendix C.
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Aims and characteristics of longitudinal analysis
Longitudinal analysis concerns repeated measurements on individuals over time
and applies a covariance structure to describe the dependence among observations
taken on the same individual while assuming independence across individuals [14].
In this way, it differentiates between changes within individuals over time from
the naturally-occurring differences between individuals in their baseline levels
and uses the consistency of these patterns over time across individuals to draw
inference [14].
The goal of longitudinal analysis is to model the individual response yij, in
terms of the covariates xi, for individuals i = 1, . . . , n, each with observations
j = 1, . . . ,mi taken at different timepoints. Each individual’s responses forms
a response vector, yi = (yi1, . . . , yimi), with mean E(Yi) = µi and variance-
covariance matrix Σi. Responses can be modelled as a linear combination of
fixed effects and random effects, known as a mixed effects model.
Regression model setup with mixed effects
The longitudinal mixed effects model (LMEM) takes the following form adapted
from Laird and Ware [26]. For individual i, we take measurements on a response
variable, p main effects, and q random, or individual-specific effects, giving the
regression equation
yi = Xiβ + Zibi + εi (3.4)
where ε ∼ N(0, σ2I), and errors are mutually independent.
The fixed effects coefficients β = [β1, . . . , βp]′, corresponding to the fixed effects
Xi, take the same value for all observations on all individuals. The random effect
coefficients bi = [bi1, . . . , biq]′, corresponding to the random effects Zi, take the
same value for all observations on the same individual and sum to zero across
individuals. The bi are assumed to be distributed normally, independently of each
other and of the errors εi [26]. The yi are independent of each other and have
marginal distribution N(Xiβ, σ2I + ZiDZ′i) for fixed β [26].
The parameter σ2 is the variance of the error εi that remains after all population-
level parameters (i.e. the fixed effects) and individual-level predictors (i.e. the ran-
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dom effects) have been fitted. Hence σ denotes the within-individual or residual
standard deviation – how far away the observations on each individual fall from
his or her fitted curve. Thus, σ is the natural choice for a measure of variability
about an individual’s biomarker trend.
Parameter estimation and model fit
The parameters β and σ2 can be estimated by maximizing the profiled restricted
log-likelihood of the parameters (known as restricted maximum likelihood or
REML estimation) using a combination of the Expectation-Maximization (EM)
algorithm and Newton-Raphson iteration. The derivation for this is covered in
detail by Pinheiro and Bates [37] and summarized in Appendix C. Maximum
likelihood estimation can also be used, although REML estimation is preferred as
it produces more consistent estimators [37]. The model fit can be checked using
the Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC)
as defined in Appendix C.
3.4.2 Application of the LMEM to the LCPW scheme
Implementation of the LCPW scheme begins with the fitting of an appropriate
LMEM to observations on all individuals in the study with fixed and random ef-
fects relating to time. This fits a separate CD4 trend to each individual. The sole
purpose of fitting the LMEM is to obtain an estimate for the residual standard
deviation σ and hence an approximate fit should be adequate, and in simulations
later on we explore the robustness of the LCPW scheme to error in the estimate
of σ resulting from an approximate fit. The estimate σ̂ is then used in (3.2) to cal-
culate the conditional probabilities {Pij}. Subsequent weights are then calculated
using (3.3) and a duplicate final timepoint created for the leftover weight. In this
way, the LMEM acts as an auxiliary weight model for the LCPW scheme.
3.4.3 Context and comparisons
The LCPW scheme differs substantially from the first-of-two schemes that we
described previously. While the FOT U/W scheme does not use weights and the
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FOTW scheme splits an individual’s total weight of 1 between just one or two ob-
servations, the LCPW scheme assigns weights to all observations including those
below the threshold, causing a wider spread of weight across possible event times.
The dataset considered by the Cox analysis is thus composed of a large group of
differentially correlated and weighted event times, clustered by individual, and
so adjusting the analyses for this correlation is essential to obtain a reliable re-
sult.
If we again refer to Figure 3.5, it would be natural to consider simply using the
fitted curve for an individual as estimated by the LMEM to estimate the time
to the event, as given by the timepoint where the curve crosses the specified
threshold (marked by a “×” on the graph). While a seemingly sensible approach,
there are a couple of clear issues. Firstly, as will be seen in the WAHIV dataset,
the number of observations on individuals can vary widely, with some individuals
having as few as 2 observations in the study time. An LMEM fitted curve is not
likely to accurately represent the underlying biomarker profile of such individuals.
Secondly, this approach does not consider the error between the fitted curve and
the true biomarker profile due to variability in the biomarker measurements,
which leads to uncertainty over where the true endpoint lies. A total weight of
1 is then placed on a single timepoint which may not be the true endpoint. The
LCPW scheme incorporates this uncertainty by “spreading” the total weight of
1 over all of the individual’s observation times according to their conditional
probabilities of being the true endpoint, leading to higher accuracy in the final
Cox analysis.
3.4.4 Hypothesis tests involving multiple observations on
each individual
In standard Cox regression analysis with survey-style weighting, each individual
contributes at most one component to the likelihood based either on an observed
event time or a censored time at which he or she is lost to follow-up. However, the
problem of interest in this thesis involves situations where multiple measurements
are taken per individual and, under the weighting schemes that we present later,
this may result in multiple event times being recorded for each individual. The
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ordinary Cox model variance estimate treats each observation as independent of
all others, which is not a valid assumption when intra-subject correlation may
exist.
Where multiple event times exist for a subject, the parameter estimates in Cox
regression remain the same, but the variance estimate for β̂ is replaced with
a robust variance estimate computed using a grouped jackknife procedure [45].
Jackknifing systematically leaves out one or more observations from a dataset,
such that the observation(s) left out at each step are independent of the observa-
tions left in, and calculates a weighted variance estimate based on the variance
components calculated at each step [13, 45].
Jackknifing can can be carried out as part of the Newton-Raphson iterations
for parameter estimation. A matrix of changes in estimated coefficients can be
formed from the resulting score vector and information matrix,
D̃ = U(β̂)I−1(β̂),
and the robust estimate of variance is then given by D̃′D̃ [13, 45]. D̃′D̃ is also
known as a robust sandwich estimator since it can be decomposed into the form
V BV ′, where a correction matrix B is “sandwiched” within variance matrix V
and its transpose. D̃′D̃ has been shown to be a consistent estimator for the
asymptotic variance of β̂ [29] and can be substituted for the inverse observed
Fisher information I−1 in the test statistics of the score and Wald tests to carry
out robust versions of these tests [45]. For weighted Cox analyses, using the
modification
D̃′WD̃,
where W is the diagonal matrix of weights, adjusts the variance estimate for
weighted observations correlated within individuals [13, 45].
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3.5 Comparing and implementing the weighting
schemes
Having described each of the weighting schemes, we set up data simulations to
compare the different schemes and explore their performance under different con-
ditions which could reasonably be expected in a two-group HIV dataset.
Throughout the simulations, we defined parameters considering two types of HIV
datasets – those that use CD4 counts, and those that use CD4 percent changes.
These represent the two common forms of measurement in HIV drug efficacy
studies.
1. CD4 Count Data: At each observation time, a measurement is taken of
the patient’s CD4 T-cell count in cells per mm3. Baseline CD4 counts in
healthy and infected individuals can vary greatly, and there is debate sur-
rounding an appropriate threshold to indicate improvement on treatment.
For ease of comparison here, we define the threshold using a standard of
500 cells per mm3 [21], and hereto refer to data using this measurement as
the count data.
2. CD4 Percent Data: To reduce the effect of baseline CD4 count variabil-
ity among individuals, some researchers use the percentage of CD4 T-cells
in total lymphocytes as a CD4 measure [21]. Again, several threshold def-
initions exist for this measure, and using the WAHIV dataset, we decided
on a threshold of a 10 percentage-point improvement from the individual’s
baseline percentage. We hereto refer to such data as the percent data.
Simulations were conducted on both count data and percent data, and the results
presented and discussed in the next chapter. An application of each weighting
scheme to a dataset from the WAHIV study is presented in the final chapter,
along with a discussion of pathways for further investigation.
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Chapter 4
Comparison of the Weighting
Schemes
Having described our weighting schemes in the previous chapter, we now look
to test the the three schemes on a series of simulated datasets modelled on data
from HIV studies and compare their performance in two areas, namely:
1. Power in identifying differences between study groups, and
2. Sensitivity to differences in observation frequency distributions between two
study groups.
Since the LCPW scheme involves fitting a longitudinal mixed effects model where
model checking can be a time-consuming and labour-intensive process, we addi-
tionally seek to test the robustness of the LCPW scheme to model misspecifica-
tion. If the LCPW scheme is fairly robust to misspecification, a model that is
“close enough” to the optimal model may be used for residual standard deviation
estimation, making use of the scheme less costly in time and computation.
Each simulated dataset is composed of the observation times and CD4 T-cell
measurements (either counts or percents) of two groups of HIV-positive individ-
uals. One group consists of 100 individuals who carry the Bw4 group of alleles
(variants) of the HLA-B gene. These Bw4 alleles are known to share several
functional properties with regard to HIV infection and disease progression, and
we refer to these individuals as Bw4 -positive [42]. The other group consists of
100 non-carriers of these alleles, whom we refer to as Bw4 -negative. Our Cox
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regression (weighted or unweighted depending on the scheme) aims to determine
whether a significant difference exists between Bw4 -positive and Bw4 -negative
individuals in the time taken to reach the threshold level of improvement in CD4
measurements since beginning anti-retroviral therapy (ART). For brevity we call
this the “Bw4 difference”. Threshold levels were 500 cells per mm3 for the count
data and 10 percentage-point change from baseline for the percent data.
We would expect that incorporating more information on each individual into
the evaluation of their event time would improve the accuracy in identifying
whether a Bw4 difference exists. Thus, when compared to the FOT U/W and
FOTW schemes, we anticipated that the LCPW scheme would have higher power
under “regular” conditions (which we will define shortly), identifying the correct
proportions of significant and non-significant p-values where no Bw4 difference
exists.
It also seems reasonable that the LCPW scheme would be robust to slight mis-
specifications of the longitudinal mixed model used to fit the observations over
time, as the model fitting serves only to estimate the residual standard deviation
and no other aspects of the model are used in the weighting and subsequent Cox
regression. Consequently, we might expect that the LCPW scheme would retain
its properties within a range of standard deviations close to the true within-
individual error.
Furthermore, previous research highlights the sensitivity of the FOT U/W scheme
to differences in the frequency of observations between the two study groups [21].
Since the LCPW scheme takes all observations into account, it may correct for this
and return more accurate p-values than either of the first-of-two schemes.
All analyses in this thesis were carried out using the R statistical programming
language [40] and the survival package [45, 44]. For the LCPW scheme, LMEMs
were fitted using the nlme package [35]. In our analyses, we chose to use the
Breslow modification for ties, since simulations of equally-weighted duplicates of
data using Breslow’s likelihood gave the same results as the unduplicated data
where no correlation between the duplicates was specified. Where multiple event
times for an individual were included in the Cox analysis as weighted endpoints,
these were clustered by individual to obtain robust variance estimates. R code
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for all analyses is available upon request.
4.1 Setup of the simulated datasets
Simulated datasets were constructed for both count and percent data in which
each individual had 21 observations (including that of the time origin), spaced 3
months apart with some random perturbation, giving approximately 60 months’
worth of observations. CD4 profiles for the count data were constructed using the
formula
CD4 = α− (α− β)exp(−kt) + ε (4.1)
where
• CD4 is the individual’s CD4 count in cells per mm3,
• α ∼ Unif(500, 700),
• β ∼ Unif(α− 400, α− 200),
• k = 0.05 is the rate of growth of the CD4 counts,
• t is the time in months from beginning of ART, and
• ε is the within-individual error, distributed N(0, 502).
This results in the profile shape shown in Figure 4.1.
Figure 4.1: Simulated CD4 count profile
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and recorded for each individual.
CD4 profiles for the percent data were constructed using the formula
changebl = α− α exp(−kt) + ε (4.2)
where
• changebl is the individual’s percentage point change from baseline in CD4
T-cells as a percentage of total lymphocytes,
• α ∼ Unif(1, 17),
• k = 0.1 is the rate of growth of CD4 percentage change from baseline,
• t is the time in months from beginning of ART, and
• ε is the within-individual error, distributed N(0, 2.52).
Since baseline percentage-point change is always 0 at t0, all values of changebl
are adjusted to 0 at this time. This results in the profile shape shown in Fig-
ure 4.2.
Figure 4.2: Simulated CD4 percent profile
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and recorded for each individual.
4.2 Power in identifying differences between
study groups
Statistical power refers to the ability of a test to detect a significant effect where
one exists. An effective weighting scheme must provide sufficient power for the
Cox parameter tests. We compare the power of the weighting schemes here by
simulating datasets with varying sizes of difference between the study groups
and observing the proportion of tests that correctly detected the differences un-
der each weighting scheme. As the absolute difference constructed between the
Bw4 -positive and Bw4 -negative groups increases, an effective weighting scheme
should return an increasing proportion of significant p-values indicating that dif-
ference.
Simulated datasets were constructed for both count and percent data as described
in Section 4.1 using 21 observations on each individual. Each individual assigned
to the Bw4 -negative group had CD4 profiles constructed using the formulae in
(4.1) and (4.2) for count and percent data respectively. However, individuals
assigned to the Bw4 -positive group had CD4 profiles constructed using the for-
mula
CD4 = α− (α− β)exp[−(k + kD)t] + ε
for the count data, and
changebl = α− α exp[−(k + kD)t] + ε
for the percent data. It is important to note that no differences in the intercept
β (for count data) or asymptotic CD4 level α between the Bw4 groups were
constructed; only the rates of increase k + kD were different.
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Definitions of the terms in these formulae are the same as in (4.1) and (4.2). In
both cases, kD is the difference parameter, or difference in growth rate of the
profiles between the Bw4 -positive and Bw4 -negative groups. Testing was carried
out on the following difference parameter values shown in Table 4.1.
Table 4.1: Values of difference parameter kD tested for power under the weighting
schemes
-0.03 -0.02 -0.015 -0.01 -0.005 0Count Data 0.005 0.01 0.015 0.02 0.03
-0.06 -0.04 -0.03 -0.02 -0.01 0Percent Data 0.01 0.02 0.03 0.04 0.06
In order to simulate irregularity of observation times and loss to follow up, each
individual’s visit time numbers (excluding the t0 observation) were randomly
sampled without replacement, to match the degree distribution of visit times per
individual in the WAHIV dataset. We discuss and apply the weighting schemes
to this dataset in the next chapter. Datasets simulated in this way are considered
to follow “regular” conditions, having properties that we might expect to see in
realistic datasets of this kind.
We then applied each of the weighting schemes — the first-of-two unweighted
(FOT U/W), first-of-two weighted (FOTW) and longitudinal conditional proba-
bility weighting (LCPW) schemes to each simulated dataset of counts and per-
cents. Unweighted Cox regression analysis was then performed on the FOT U/W
dataset, and weighted Cox analyses with clustering were performed on the FOTW
and LCPW weighted datasets. For the LCPW scheme, the LMEM model fitted
had as its fixed effects Bw4 status, time (in months) and time-squared, and ran-
dom effects of time and time-squared. This fitted quadratic curves to the CD4
measurements for each individual. Curves for the percent data were constrained
to pass through the origin (i.e. have an intercept of 0).
We also used the true time-to-threshold recorded for each individual in an un-
weighted Cox analysis for comparative purposes against the weighting schemes,
recording each time-to-threshold as uncensored if it occurred before the end of
the study time, and censored at the last observation time for that individual if
not. We will refer to this as the “True” scheme.
For each scheme, three p-values were obtained for comparison — from the non-
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robust score test, the robust score test, and Wald test. The non-robust score (or
simply, score) test does not take clustering of the observations into account, as-
suming that all observations are independent of each other. The robust score and
Wald tests account for clustering between multiple observations on an individual,
and utilize a form of the robust variance estimate described in Section 3.4.4. For
the unweighted FOT U/W dataset and the dataset comprising the true times-to-
threshold, the score and robust score tests give nearly identical results. All tests
were carried out using a significance level of 5%.







where xi is the covariate for Bw4 status, which takes the value
xi =
 1, if individual i is Bw4 -positive, and0, if individual i is Bw4 -negative.
Test size where no Bw4 difference exists
The size of a test denotes the probability of rejecting a null hypothesis when it
is true, and given by the significance level of the test. Where the null hypothesis
of having no Bw4 difference is true, we want the tests performed to show a size
of 0.05, that is, having 5% of its p-values being significant at the 5% significance
level. We also expect that the p-values would be distributed Unif(0, 1). Q-Q
plots were used to compare how closely observed quantiles for each test and
scheme fall to their expected values under a uniform distribution. Figure 4.3
shows that this uniformity occurred for all the tests — score, robust score and
Wald, using the event times recorded under the True scheme. Since only one
true endpoint was recorded for each individual, no clustering existed, and so all
the tests gave similar results. The corresponding Q-Q uniform plots for the true
times-to-threshold showed approximate uniformity of the p-values.
The FOT U/W scheme, like the True scheme, had no clustering and, hence,
showed similar results regardless of which hypothesis test was used. P-values
under this scheme showed approximate uniformity in the Q-Q plots, showing
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Figure 4.3: Q-Q uniform plots of score test p-values — count data with no Bw4
difference (n=2000)
that the first-of-two unweighted scheme had the correct distribution of p-values
as well as the correct size under the null hypothesis.
The FOTW scheme worked in a similar way to the FOT U/W scheme except
for two half-weighted observations — one uncensored, the other censored, being
recorded for individuals with no above-threshold consecutive pairs but with a sin-
gle above-threshold observation at the last timepoint. Since this resulted in some
observations being correlated, the score test p-values are non-uniform, with the
p-values being overly conservative. The robust score and Wald test p-values are
closer to being uniformly distributed and show that the FOTW scheme also has
the correct approximate size when there is no difference in times-to-threshold be-
tween the Bw4 -positive and Bw4 -negative groups. When clustering is accounted
for, the FOTW scheme performs similarly to the FOT U/W scheme.
For the LCPW scheme, the robust score and Wald tests are strongly preferred
to the score test due to each individual having multiple observations causing a
high degree of clustering. In the Q-Q uniform plot for the score test, the LCPW
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p-values show substantial deviations from uniformity, being overly conservative.
However, the Q-Q plot for the robust score and Wald tests show much more
uniformity in the p-value distributions, with observed quantiles being closest to
their expected uniform values out of all the schemes.
Overall, all the schemes appear to perform well when no difference in times-to-
threshold existed between the Bw4 -positive and Bw4 -negative individuals. The
LCPW scheme appeared to fare best in this area as long as the test used accounted
for its high degree of intra-subject correlation.
Figure 4.4 shows Q-Q plots for the percent data. Similar to the count data, we
expected uniform distributions of p-values when using the true times-to-threshold.
Q-Q plots for the True scheme were consistent with this.
Unlike in the count data, there appears to be little to no difference in performance
between the FOT U/W, FOTW and LCPW weighting schemes (other than for
the score test), with all schemes showing very close adherence to the expected
uniform distribution. The FOT U/W results were similar in all tests, having no
clustering under this scheme. Using the robust score and Wald tests, each scheme
had good test size, failing to identify a significant difference in times-to-threshold
between the Bw4 -positive and Bw4 -negative groups.
Some deviations from uniformity were expected in the FOTW and LCPW score
test p-values, due to violations of the assumption of independence of all obser-
vations used in the score test. There was little deviation from uniformity in the
FOTW score test p-values, likely due to the number of subjects requiring “split”
weightings being small relative to the sample size. The LCPW score test p-values
were overly conservative in this case, as was expected.
Ultimately, all the schemes showed good test size using the robust score and
Wald tests, whether applied to count or percent data. Results for the count data
suggested that the LCPW scheme showed the best performance, but no marked




Figure 4.4: Q-Q uniform plots of p-values by weighting scheme — percent data
with no Bw4 difference (n=2000)
Power in detecting differences — count data
Figure 4.5 displays the proportions of p-values significant at the significance level
of 5%, or power, for each kD value for the count data. The graphs are asymmet-
rical, which is reasonable, given that the exponential function which we used to
create the CD4 profiles is not symmetrical. We expected that the proportion of
significant p-values when kD = 0 would be 0.05, the probability of a Type I error
(i.e. detection of a significant effect where none exists). Using the score test on the
count data, all schemes had approximately 0.05 of their p-values being significant
at kD = 0 except the LCPW scheme, which had a proportion below 0.05. This is
consistent with the LCPW p-values being overly conservative when clustering is
not accounted for in the Cox analysis. Using the robust score and Wald tests on
the count data, however, gave the approximate correct proportion of 0.05 for all
schemes.
Curves for the True scheme show the expected power at each difference parameter
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Figure 4.5: Statistical power by difference parameter and weighting scheme —
count data (n=2000)
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tested. While none of the other schemes showed the same power as the True
scheme for each test used, they were fairly close to one another. The FOTW
scheme was slightly more powerful than the FOT U/W scheme when kD 6= 0
even though the number of individuals who had a pair of 0.5 weights recorded
was small relative to the sample size. The extra weight assigned to uncensored
endpoint observations for those individuals had a substantial impact on the Cox
weighted score function, increasing the power to distinguish between the Bw4 -
positive and Bw4 -negative groups.
The power curves for the FOT U/W and True schemes did not vary with the
test used since no clustering existed for those schemes. However, the FOTW and
LCPW schemes showed slightly lower power curves when the score test was used
compared to the robust score and Wald tests, since the clustering present made
the p-values obtained in the score tests under those schemes more conservative.
This difference was especially marked in the LCPW curve.
When using the robust score or Wald tests, the FOTW scheme generally showed
the highest power when kD 6= 0, followed by the FOT U/W scheme, with the
LCPW scheme having the lowest power. The LCPW scheme, therefore, appears
to be the most conservative of the schemes in the detection of a difference between
the study groups under this scenario, which was inconsistent with what we had
expected.
Power in detecting differences — percent data
Figure 4.6 displays the power at a 5% significance level for each kD value for the
percent data.
Using the score test on the percent data yielded a proportion of significant p-
values for the True scheme at kD = 0 that was slightly lower than expected, but
still close to 5%. The other schemes were more powerful than the True scheme
at kD = -0.06 using the score test, with the LCPW scheme having the highest
power. However, the LCPW scheme did not have the correct size of 0.05 for the
score test, invalidating the comparison.
As with the count data, the power curves for the FOT U/W and True schemes did
64
Figure 4.6: Statistical power by difference parameter and weighting scheme —
percent data (n=2000)
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not change with the test used. However, using the robust and Wald tests corrected
for the clustering and resulting conservativeness of the FOTW and LCPW p-
values. For both tests, the LCPW scheme had the highest power overall, with
the FOT U/W and FOTW schemes having similar power throughout. This was
consistent with what we expected. Further analysis will be needed to assess why
the True scheme is less powerful than the other schemes for negative kD.
Notes on the power curves
The shape of the power curves for both the count data and percent data is
asymmetric, although the percent power curves are more asymmetric than the
count power curves. This is likely due to differences in the setup of the simulated
datasets between the count and percent data. While the CD4 count profiles having
different values at t0, with the β values determined by the randomly-selected α
values, the CD4 percent profiles all begin at 0. Also, since profiles are constructed
using exponential curves, the differences in true time-to-threshold values between
different kD values are not proportional to the changes in kD. For example, in
the percent data, although the kD values of -0.02, 0 and 0.02 are equally spaced,
the resulting times-to-threshold are not, even for the same α and ε values. This
is likely to result in different proportions of p-values being significant at these
kD.
We may be interested in forming symmetric power curves for the schemes, per-
haps for ease of comparison or to model in some way. These studies, however,
are beyond the scope of this thesis, and would be recommended for further ex-
ploration.
4.3 Sensitivity to differences in observation fre-
quency between study groups
Research carried out on simulated CD4 count profiles by James and McKinnon
[21] showed that time-to-event analyses using the first-of-two unweighted ap-
proach were sensitive to differences in the frequency of observations between the
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two study groups. This is reasonable when we consider that the more frequently
observations are taken, the more likely it becomes to have an above-threshold
consecutive pair occur earlier in the study. In developing the LCPW scheme, we
hoped that it would be less sensitive to these differences and return p-value dis-
tributions that were closer to those under the True scheme than the first-of-two
unweighted and weighted approaches.
To test this, we simulated CD4 count data and percent data using (4.1) and (4.2),
with no difference between the equations used for the Bw4 -positive and Bw4 -
negative groups. In this scenario, we did not seek to match the degree distribution
of visit times per individual in the WAHIV dataset as was done in Section 4.2,
as this would have affected observation frequency. For both groups, observations
were taken over a period of 60 months as before, however, individuals in the Bw4 -
negative group had 21 observations spaced 3 months apart on average, while
Bw4 -positive individuals had 11 observations spaced an average of 6 months
apart. Using the true times-to-threshold, therefore, there should be no difference
by Bw4 status.
Simulation results
Figures 4.7 and 4.8 display the results of 2000 simulations on the count and per-
cent data, respectively, and the results for both counts and percents are largely
similar. Using the True scheme for all tests, there was no difference in times-
to-event by Bw4 status, leading to a uniform distribution of p-values. This was
expected since the true times-to-event are calculated using the formulae for con-
struction of the datasets, without any reference to the visit times. The FOT
U/W and FOTW schemes both produced anti-conservative p-values, resulting
in positively-skewed p-value distributions, and performed similarly on the score,
robust score and Wald tests. This result was expected, given previous work on
the subject [21]. However, the LCPW scheme performed much worse than ex-
pected, having the highest skew out of all the schemes. This occurred regardless
of the test used, with at least 80% of p-values being significant under the LCPW
scheme.
This could be due to the weighting procedure for the LCPW scheme. Since the
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Figure 4.7: P-value distribution by weighting scheme using different observation
frequencies with no Bw4 difference — count data (n=2000)
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Figure 4.8: P-value distribution by weighting scheme using different observation
frequencies with no Bw4 difference — percent data (n=2000)
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weights for observations depend heavily on the values of previous observations,
having more observations on an individual could bias heavier weights to the left.
As an example of this, we examine two identical CD4 count profiles with different
observation frequencies, based on typical profiles from our simulations. Figure 4.9
shows this graphically, with the upper profile having observations taken twice as
frequently as the other. The shaded areas show the conditional probabilities {Pij}.
Under the LCPW scheme, the weight assigned at any timepoint is equal to the
conditional probability at that timepoint, Pij, multiplied by the probabilities of
having not reached the threshold at earlier timepoints. The largest weight for that
individual, therefore, would be placed at the timepoint which maximises:
1. The shaded area at that timepoint, multiplied by
2. Unshaded areas from previous timepoints.
The circled timepoints highlight where that maximum weight is placed for each
profile. It now becomes clear how having more frequent observations on an indi-
vidual can cause more weight to be placed at earlier timepoints. These weights
are then used in the weighted Cox analysis, which pushes the times-to-threshold
of the more frequently-observed group to the left, and those of the less-frequently
observed group to the right. Hence, when one study group is observed signifi-
cantly more frequently than the other, this can cause the Cox analyses performed
using the LCPW scheme to detect differences between the times-to-threshold of
the groups that do not actually exist, and our simulations show that it does so
more readily than the FOT U/W or FOTW schemes.
Following these results, we would recommend that the number and frequency of
observations be compared between study groups for any dataset where such anal-
yses are to be applied. If observational frequency between the groups is substan-
tially different, the FOTW scheme is preferred over the LCPW scheme, although
the analyst should be aware that all the schemes give anti-conservative results in
this scenario and should be used with caution.
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Figure 4.9: LCPW weightings for identical CD4 count profiles of individuals with
different observation frequencies
4.4 Robustness of the LCPW to misspecifi-
cations of the longitudinal mixed effects
model
4.4.1 Effects of the LMEM residual standard deviation on
the weights
In using the LCPW scheme, the sole goal of fitting the longitudinal mixed effects
model is to obtain an estimate of σ̂, the residual (or within-individual) standard
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deviation, which is used as the standard deviation in a normal distribution centred
at the CD4 data point for the calculation of the probability Pij. Suppose we
could choose any value of σ to use in the weighting procedure. In figure 4.10,
which displays the same count profile with different choices of σ, the shaded
areas show the probabilities {Pij} and the circled timepoint tj shows where most
of the weight is placed within the individual’s observations. It clearly illustrates
that using values of σ that are much larger or smaller than the estimate σ̂ can
result in drastically different values of Pij, which in turn affect the weights {wij}
and the timepoint on which most of the weight is placed within an individual’s
observations.
As the choice of σ decreases towards 0, the normal distribution that we have set
up on each observation shrinks around the centre of the distribution, i.e. the ob-
servation itself, and the probabilities {Pij} would be close to 0 if the observation
is below the threshold, close to 0.5 if it is on the threshold, and close to 1 if it is
above the threshold. A weight of 1 would be assigned to the first above-threshold
observation, with previous and subsequent weights being 0. This essentially re-
duces the LCPW weighting scheme to a first-to-threshold approach, with only the
first above-threshold observation being recorded uncensored as the endpoint for
that individual. Increasing the value of σ from 0 increases the consideration that
is given to surrounding observations, until that optimal value of σ is reached, be-
ing the estimate σ̂ from the LMEM fit. An inordinately large value of σ, however,
results in the majority of weight being placed on earlier observations, biasing the
time-to-threshold to the left. In the extreme case, choosing a large σ results in a
large weight being placed on the CD4 measurement at t0, and the resulting Cox
analysis lacks power in detecting any difference between the study groups.
4.4.2 Testing LCPW robustness to error in σ
Knowing this, we wanted to test how sensitive the weighting and resulting Cox
analyses would be to errors in σ̂, such as those stemming from a poorly-fitted
LMEM. Fitting LMEMs can be costly in time and computation, and if results
obtained from Cox analyses using the LCPW scheme were very sensitive to error
in σ̂, the analyst would have to take greater care in ensuring a good LMEM fit.
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Figure 4.10: A typical CD4 count profile with σ much smaller (top) and larger
(bottom) than the estimate σ̂ and the resulting probabilities Pij
However, if the LCPW Cox results were relatively robust to error in σ̂, the analyst
could save time and computational expense by fitting a “good enough” LMEM,
whereby the estimate of σ̂ obtained would return accurate weights and resulting
p-values.
Simulated datasets were set up on both count and percent data as described in
Section 4.1 with the number of observations per individual matching the degree
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distribution, or distribution of follow-up visits per individual, from the WAHIV
dataset. No differences in the profiles were constructed between the Bw4 -positive
and Bw4 -negative groups. We ran Cox analyses using the LCPW scheme on each
dataset using a range of pre-set residual standard deviation values in place of
ones obtained from LMEM fitting. For count data, where the error built into the
profiles had standard deviation σε = 50, we used σ values ranging from 40 to 60.
For percent data, where the built-in error had standard deviation σε = 2.5, we
used σ values from 2.0 to 3.0. We expected these ranges to cover a reasonable
amount of error from misspecification of the LMEM.
Figures 4.11 and 4.12 display the proportion of significant p-values from weighted
Cox analyses performed using the specified residual standard deviations to cal-
culate the weights. As there was no significant difference in times-to-threshold by
Bw4 status, the proportion of significant p-values in an accurate test should be
0.05.
As with previous simulations, the score test gave overly conservative p-values,
with lower proportions of p-values significant at the 5% significance level than
the robust score and Wald tests. For the count data, the proportion of significant
p-values was just under 0.05 for both the robust score and Wald tests, with the
robust score test having proportions closer to 0.05. For the percent data, the
proportion of significant p-values was very close to 0.05 for both the robust score
and Wald tests. We would, therefore, recommend using the robust score test over
the Wald or score tests.
For both sets of data, the significant p-value proportions held constant within
the ranges of σ chosen. This suggests that when the robust score test is used, the
LCPW scheme has good test size within a reasonable range of error in the esti-
mation of σ̂. It is important to note here that we have only tested the robustness
of the schemes to changes in σ when no Bw4 difference exists. We have not yet
tested the effect of using the above range of σ values where a difference exists
between the Bw4 groups, and would be looking for significant p-values to hold
constant within the range, albeit with higher power. This would require more
extensive simulations to test the power of the different schemes on the range of
σ values, similar to those undertaken in Section 4.2, and was not undertaken
in this thesis. Furthermore, in this round of simulations, we have assumed that
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Figure 4.11: Proportion of significant p-values by LMEM residual standard devi-
ation — count data (n=2000)
Figure 4.12: Proportion of significant p-values by LMEM residual standard devi-
ation — percent data (n=2000)
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the frequency of observations is, on average, equal between the groups. If this
assumption is violated, as shown in Section 4.3, the robustness of the schemes
will be severely affected for all σ.
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Chapter 5
Application and Discussion of the
Weighting Schemes
In the previous chapter, we compared the first-of-two unweighted (FOT U/W),
first-of-two weighted (FOTW) and longitudinal conditional probability weighting
(LCPW) schemes using Cox regression on simulated count and percent datasets,
comparing their performance in several areas. We now turn back to the HIV
study which motivated this project, applying each of the weighting schemes to
data from a subset of the WAHIV study measuring time-to-improvement on anti-
retroviral treatment. Using percent data from this study, we aim to find out
whether a difference in the time-to-threshold exists between the Bw4 -positive
and Bw4 -negative individuals, and whether this result is consistent across the
different weighting schemes.
Finally, we evaluate how the weighting schemes, particularly the FOTW and
LCPW schemes which involve novel ways of weighting observations, contribute
to current HIV time-to-event methods. We also discuss issues and questions which
merit further study.
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5.1 Application of the weighting schemes to the
WAHIV dataset
5.1.1 Study description
Our dataset consists of distinct observations taken at different timepoints, on 86
Caucasian, HIV-infected males from the Western Australian HIV Cohort Study
who had not previously received antiretroviral therapy (ART) [30]. Each individ-
ual was assigned an arbitrary subject identification number. The time origin t0
for each individual was the time at which they began ART, where their baseline
CD4 T-cell measurement was taken, being CD4 T-cells as a percentage of total
lymphocytes (from hereon referred to as “CD4 percentage”). Observation times
were recorded in months from the start of ART, during which a new blood test
was performed on each individual, and a new CD4 percentage was recorded. In-
dividuals with missing covariate values were deleted from the analysis, with the
assumption that the covariates were missing at random.
Also recorded was whether or not each individual possessed Bw4 alleles, a variant
grouping of the HLA-B gene, either heterozygously (i.e. having one Bw4 allele
per somatic cell) or homozygously (i.e. having two Bw4 alleles per somatic cell).
The corresponding variable is an indicator with the value 1 if the individual is
Bw4 -positive (i.e. possesses Bw4 alleles in homozygous or heterozygous form),
and 0 if the individual is Bw4 -negative (i.e. does not possess Bw4 alleles at all).
Fifty one individuals in the study were Bw4 -positive, and thirty five were Bw4 -
negative. Previous evidence has shown that Bw4 homozygosity is associated with
impaired recovery of CD4 T-cells after initiation of ART, even though it confers
a protective effect against AIDS and decreases the risk of HIV transmission in an
infected individual [42].
Our goal in this analysis was to use the weighting schemes that have been devel-
oped in this thesis to determine if possession of the Bw4 gene has a significant
effect on the response of HIV patients to treatment. Our measure of choice is
the time taken for each individual’s CD4 percentage to increase by 10 percentage
points from their baseline, which was selected from graphs of the CD4 profiles to
be a reasonable indicator of practically significant increase. The Cox model fitted
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Figure 5.1: Time spent in the study by Bw4 status for individuals in the HIV
study
was of the form
hi(t) = exp(β′xi)h0(t)
where xi is the indicator variable for Bw4 status.
Times spent in the study ranged from just over 1 month to nearly 48 months with
a fairly even spread of times, while the number of observations on an individual
ranged from 1 to 27 with most individuals having either very few (between 1 and
5) or many (10 to 19) observations. Most individuals averaged 1 to 4 months
between visits. The corresponding distributions by Bw4 status are shown in Fig-
ures 5.1, 5.2 and 5.3.
There are some noticeable differences between the Bw4 -positive and Bw4 -
negative groups. In particular, the Bw4 -positive individuals have a wider range of
times between observations with around 12.5% of Bw4 -positive individuals hav-
ing gaps of more than 4 months between observations as opposed to around 5% of
Bw4 -negative individuals. With longer gaps between observations, the time-to-
event for the individual tends to be biased to the right, as they have long periods
during which they may reach the threshold but be unobserved. In the simula-
tions in Section 4.3 we saw that the results of Cox regression analyses testing for
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Figure 5.2: Number of observations per person by Bw4 status in the HIV study
Figure 5.3: Months between observations for individuals in the HIV study by Bw4
status
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a Bw4 effect can be greatly biased if differences in observation frequency exist
between the Bw4 -positive and Bw4 -negative groups, and we must be aware of
this possibility here.
Figure 5.4 shows a plot of the data, displaying each individual’s trend in CD4
percentage change. There appears to be a generally increasing trend with some
individuals reaching and exceeding the threshold of a 10 percent change from
baseline on treatment, and others not reaching the threshold at all. With the
variation in the data and large sample size, it is difficult to tell if there is a differ-
ence in when the Bw4 -positive and Bw4 -negative individuals reach the threshold.
Hence, we now apply each weighting scheme in turn.
Figure 5.4: Change in CD4 percentage of total lymphocytes after beginning ART
5.1.2 First-of-Two Unweighted Analysis
The first-of-two unweighted (FOT U/W) approach takes only the first of two
consecutive above-threshold observations to be the recorded endpoint event for
each individual, and if no above-threshold consecutive pairs exist, the individual’s
last observation is censored. Implementing the FOT U/W approach resulted in
47 out of the 86 individuals (55%) having censored observations recorded as their
event times.
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We first carried out a Cox PH regression on the data using the covariate Bw4
status. As the unweighted scheme takes only one observation from each individ-
ual into the analysis, we do not need to consider clustering or robust variance
estimation. Results are shown in Table 5.1. Under the FOT U/W scheme, Bw4
status is not quite significantly correlated with different times-to-improvement on
ART at the 5% significance level using any of the tests.
Table 5.1: Cox regression on the WAHIV dataset using the FOT U/W scheme
Coefficients β s.e.(β)
Bw4 status -0.5981 0.3225
Hypothesis tests χ2 DF Sig.
Wald test 3.44 1 0.06363
Likelihood ratio test 3.44 1 0.06353
Score (log-rank) test 3.54 1 0.05985
Since the unweighted approach gives us one distinct event time for each individual,
we can present the Kaplan-Meier survival curves for the Bw4 -positive and Bw4 -
negative groups, along with their respective 95% confidence interval bands (given
in dashed lines), in Figure 5.5. As the other weighting schemes may result in
multiple observations on an individual, Kaplan-Meier curves cannot be produced
for them.
The survival curves look quite different for the Bw4 -positive and Bw4 -negative
groups; however, there is some slight overlap in their confidence intervals. This
is consistent with the p-value for Bw4 status being just slightly larger than
5%.
5.1.3 First-of-Two Weighted Analysis
The First-of-Two Weighting (FOTW) scheme works in a similar way to the first-
of-two unweighted approach, except that if no consecutive pairs exist for an in-
dividual and their final observation is above-threshold, that final observation is
split into two equally-weighted observations, with one being censored and the
other uncensored. We implemented the FOTW scheme and ran a weighted Cox
regression analysis on the weighted dataset. Since some individuals could have two
recorded endpoint observations with different censoring values, we incorporated a
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Figure 5.5: Kaplan-Meier survival curves by Bw4 status
clustering term into the Cox model to account for any correlation between those
two observations on relevant individuals. Results are shown in Table 5.2.
Table 5.2: Cox regression on the WAHIV dataset using the FOTW scheme
Coefficients β s.e.(β)
Bw4 status -0.6429 0.3151
Hypothesis tests χ2 DF Sig.
Wald test 4.32 1 0.03764
Likelihood ratio test 4.17 1 0.04104
Score (log-rank) test 4.3 1 0.03812
Robust score test 4.29 1 0.03836
Using this approach, all the tests show that Bw4 status is significant at the 5%
level. Assuming proportional hazards, the relative risk of reaching the threshold
of a 10 percentage point increase in CD4 percentage for a Bw4 -positive individual
is about half (exp(-0.6429) = 0.5259) that of a Bw4 -negative individual, at any
given time t during the study. Hence Bw4 -positive individuals are expected to
reach the threshold at a later time than Bw4 -negative individuals.
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Comparing the number of events between the FOT U/W and FOTW analyses,
only 4 individuals had their final observation duplicated and weighted. Out of 86,
this is not a high proportion, yet its effect was substantial enough to change the
final p-value from non-significant to significant at the 5% level. This is yet another
illustration of the importance of incorporating uncertainty into such analyses
using methods such as these weighting schemes.
On the other hand, the small proportion of individuals with weighted observations
under this method explains the small difference in p-value between the likelihood
ratio and score tests, which do not use robust variance estimates, and the Wald
and robust score tests which do. This is consistent with the results of the simula-
tions, where the FOTW method produced similar p-values regardless of whether
we used a robust or non-robust test in our Cox analysis. However, should the
proportion of individuals with weighted observations be large, large discrepan-
cies could occur between the robust and non-robust tests, as can be seen in the
implementation of the LCPW scheme which follows.
5.1.4 Longitudinal Conditional Probability Weighted
Analysis
The Longitudinal Conditional Probability Weighting (LCPW) scheme involves
fitting a longitudinal mixed effects model (LMEM) to the data to obtain the
residual standard deviation, which is used to calculate the weight assigned to each
observation on an individual. Leftover weight is assigned to a censored observation
at the final timepoint, so that all weights on an individual’s observations sum to
1.
We fitted an LMEM to the dataset with months (since the start of ART) and
months-squared in the fixed effects. We also fitted the same terms as random
effects, giving each individual a separate curve. As the change in CD4 percentage
at t0 must by definition be zero for all individuals, we added a constraint to both
the fixed and random effects, forcing the modelled curves to pass through the
origin. A summary of the model fit is given in Table 5.3, from which we obtained
the residual standard deviation of 3.335.
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Table 5.3: Summary of the LMEM fitted to the WAHIV dataset
Fixed Effects
Coefficient Standard Error DF t-value Sig.
Bw4 status 2.73519 0.38081 85 7.18263 0
Months 0.57832 0.07644 758 7.56600 0






We then calculated the weights for each observation and carried out a weighted
Cox regression on all observations, accounting for intra-subject correlation, given
that each individual could have up to 27 observations. Results are shown in
Table 5.4.
Table 5.4: Cox regression on the WAHIV dataset using the LCPW scheme
Coefficients β s.e.(β) Robust s.e.(β)
Bw4 status -0.4162 0.2724 0.2258
Hypothesis tests χ2 DF Sig.
Wald test 3.4 1 0.06527
Likelihood ratio test 2.32 1 0.1273
Score (log-rank) test 2.37 1 0.1239
Robust score test 3.52 1 0.06073
From all tests, Bw4 status appears to be just non-significant as a predictor of
relative risk for threshold improvement on treatment; however, as in the simu-
lations from the previous chapter, the difference between the p-values produced
by the robust and non-robust tests can be clearly seen. We reject the p-values
from the likelihood ratio and score tests as being overly conservative, and report
the more accurate p-values from either the Wald or robust score test. The Wald
and robust score p-values here are similar to those produced by the FOT U/W
scheme (around 0.06).
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5.2 Discussion and areas for further study
A summary of our results from the WAHIV dataset is presented in Table 5.5,
showing the p-values produced under each scheme for the score, robust score
(where duplicate observations are weighted) and Wald tests. When comparing
the p-values under the FOT U/W and FOTW schemes, we observed a substantial
impact on the significance of the resulting p-values at the 5% significance level
when just 4 individuals out of 86 were assigned the split weightings under the
FOTW scheme. We could expect to see an even greater difference in the p-values
in datasets with a higher proportion of such individuals. However, the small
proportion of weighted individuals under the FOTW scheme appeared to result
in the small difference between the p-values from non-robust and robust tests.
There was a much more pronounced difference between the p-values of the non-
robust and robust tests under the LCPW scheme, as most of the individuals in
the study had multiple weighted event times under this scheme.
Table 5.5: Summary of the p-values obtained from implementing the weighting
schemes on the WAHIV dataset
Score test Robust score test Wald test
FOT U/W 0.05985 - 0.06363
FOTW 0.03812 0.03836 0.03764
LCPW 0.1239 0.06073 0.06527
From these analyses, we can see that the choice of weighting method to identify
the endpoint(s) for an individual in a time-to-event study may affect the conclu-
sions drawn. In the case of our HIV dataset, the FOTW approach and LCPW
approach lead to different conclusions regarding the significance of Bw4 status,
although looking at the analyses from all three schemes suggests that the sig-
nificance of the Bw4 effect is marginal at the 5% level. Ultimately, the choice
of weighting method and conclusion drawn is left to the judgment of the ana-
lyst, and our aim is to draw attention to the need for schemes that incorporate
endpoint uncertainty and their importance to studies of this kind.
We return to the two key questions presented in Section 1.1.1. Firstly, we wanted
to investigate whether we could find the timepoint at which a patient most likely
reached the threshold, given that their visits were irregular and assuming that
their CD4 measurements were a true representation of their underlying measure-
86
ments. Secondly, since we know that in practice, short-term measurements fluc-
tuate about the true underlying trend, we wanted a way to determine their most
likely time-to-threshold by modelling this trend. Both the FOTW and LCPW
schemes present solutions to the first question through the assignment of weights
to an individual’s visit times based on the observed CD4 measurements made
at those times. The weight for a timepoint is based on some probability corre-
sponding to how likely the individual is to have reached threshold at that time,
and hence the weights are a representation of the likelihood of that timepoint
being the endpoint for that individual. While the FOTW scheme applies only to
particular timepoints and a simple split into two weights of 0.5 each is applied,
the LCPW scheme applies to all visit times on an individual and weights are
applied based on a fitted LMEM. Fluctuations about an individual’s true trend
are accounted for by the residual standard deviation of σ in the LMEM, which
represents the variation in measurements about the curve for each individual.
Hence, only the LCPW scheme presents a solution to the second question by
allowing the modelling of individual trends and the use of that model to weight
timepoints.
We now wrap up our exploration of the weighting schemes and this thesis by
discussing several questions and issues of interest which remain, relating mainly
to the FOTW and LCPW schemes.
The FOTW scheme was proposed as an improvement on the commonly-used
FOT U/W system, and it was shown through simulations to perform reasonably
well, with good size and power in the weighted Cox regression. Its ease of use
and small cost in time and computation are advantages over the LCPW scheme.
Its main limitations are its sensitivity to differences in observation frequency
between the study groups, where it tends to produce anti-conservative p-values,
and the inherent difficulty in determining the weights to use when duplicating
a single, final above-threshold observation on an individual, where no previous
above-threshold consecutive pairs have been found. Modifications to the FOTW
scheme could be explored to improve its performance and accuracy in both these
areas.
Although the LCPW scheme is not the first to rely on an auxiliary weight model,
we have yet to find any that rely on models that are as complex as the LMEM.
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Previous schemes have used logistic, probit or non-parametric models [25, 39],
which have far fewer distributional assumptions. We showed through simulations
in the previous chapter that the size of the LCPW scheme is at least as good
as that of the FOT U/W and FOTW schemes where no difference in times-to-
threshold exists between study groups, and that its power is close to that of the
FOT U/W and FOTW schemes when a difference exists. These early results show
that the LCPW scheme has potential as a weighting scheme for time-to-event data
where endpoint uncertainty exists. It should be noted that the simulations were
performed on large samples, and the number of simulations was itself very large
(2000). Hence, we can only comment on large-sample, asymptotic properties using
these results. The small sample properties of the LCPW scheme have yet to be
determined, and more study will be needed in this area.
The LCPW scheme retains its size within a range of values around the LMEM
residual standard deviation estimate σ̂, suggesting that it may be quite robust
to mis-specification of the LMEM. The extent of this robustness can be explored
by increasing the range of σ values tested to determine the error tolerance in
the scheme. It would also be helpful to determine if this error tolerance changes
as other conditions change, such as the extent of difference between the study
groups or having different sample sizes between the groups.
Furthermore, in these simulations and in our WAHIV dataset analysis, we only
included one parameter (Bw4 status) in both the auxiliary LMEM and the subse-
quent weighted Cox model (besides the time parameters in the LMEM). This has
been done in other proposed weighting schemes for Cox regression that rely on an
auxiliary weight model (the weighting scheme proposed by Pugh, Robins, Lipsitz
and Harrington [39] assumes use of the same parameters in the auxiliary weight
model and the weighted Cox model, as do the schemes proposed by Kim and
Skinner [25]). Specifying the same parameters (besides time) for the LMEM and
weighted Cox regression models seems reasonable, given that parameters found
to be significant in the LMEM should also be tested in the Cox model.
One major limitation of the LCPW scheme is its poor performance in cases where
observation frequency differs greatly between the study groups. In this situation,
the p-values obtained from an LCPW-Cox regression approach are highly anti-
conservative, and we postulated in Section 4.3 that this is due to the conditional
88
nature of the probabilities from which the weights are calculated. The weights
from the LCPW scheme are highly dependent on the rank order and number of
observations, and modifications to the LCPW scheme to account for these would
be worth investigating.
We can think of the weights derived from both the FOTW and LCPW schemes as
variables themselves. Weights from the FOTW scheme may have some unknown
distribution dependent on the frequency and value of previous observations, while
weights from the LCPW scheme may have a distribution dependent on the rank
order and number of the observations on the individual in question. In their pro-
posed weighting scheme, Kim and Skinner [25] suggest smoothing of the weights
using the conditional expectation of the calculated weight given the response and
censoring variables. Similar smoothing mechanisms could be explored here, using
the conditional distribution of the weights in the FOTW and LCPW schemes.
This may improve the robustness of the schemes to variation in the number of
observations between individuals as well as their accuracy in weighting.
5.3 Final remarks
The use of weights on observations on an individual to determine endpoint oc-
currences for Cox regression is a novel way of accounting for the uncertainty in
endpoints when fluctuations exist in the measurements which determine whether
or not an endpoint event has occurred. In this thesis, we proposed two weight-
ing schemes that could be applied to such time-to-event data — the first-of-two
weighting (FOTW) scheme and the longitudinal conditional probability weight-
ing (LCPW) scheme, and compared them to the commonly-used first-of-two un-
weighted (FOT U/W) approach and the true calculated times-to-event in a series
of simulations. When used on a dataset from the WAHIV study of times to im-
provement on antiretroviral therapy, the p-values produced by each scheme (using
robust tests when applicable) were not substantially different, although they led
to different conclusions at a 5% significance level.
Our findings indicate that there is much potential for the use of weights in this
manner in Cox analyses, although some limitations were also discovered during
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the simulations and discussed. Some directions for further investigation of the
behaviour of the FOTW and LCPW weighting schemes and suggestions for im-
provement were outlined, and more work will be needed to develop these weighting
schemes into robust, reliable methods. We believe that with some refinement, the
weighting of observations to deal with endpoint uncertainty could be a valuable
addition to the survival analysis toolkit, and particularly to the HIV biomedical





This appendix covers an intuitive implementation for calculating the product
limit estimate described in Collett [9], as derived in Section 1.2.2.
Suppose that in a study of n individuals, there are r distinct uncensored event
times, r < n. More than one individual may reach an event at the same time,
which results in ties at that distinct event time. Censored observations may fall
anywhere on this time scale, but do not themselves result in a ranked event time.
The event time t(i), where i = 1, . . . , r, forms the start of a time interval to the
next event time. As an illustration, Figure A.1 below shows study times for six
individuals, each with his or her own t0i. Below it, Figure A.2 shows how the
study times are converted to a time scale with a fixed t0 left endpoint in the
bottom diagram with the uncensored event times ranked accordingly.
We denote ni to be the number of individuals yet to experience the event of
interest just before time t(i) and di to be the number of individuals who experience
an event at time t(i). There are, therefore, di individuals who experience an event
within the time interval t(i)−∆t to t(i), where ∆t is infinitesimally small, and the
probability of an event occurring within [t(i)−∆t, t(i)] is then di/ni. The estimated
probability of “surviving” through this interval past t(i) to just before the next
interval t(i+1), is 1− di/ni, or (ni− di)/ni. Here we will use “surviving” to denote
reaching the end of the present interval without experiencing an event.
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Figure A.1: Event times along a chronological time scale
Figure A.2: Event times along the survival time scale
In the cases where censored event times appear to occur at the same time as
uncensored events, the censored event times are taken to occur immediately after
uncensored events when estimating the above probabilities [31][9]. The assump-
tion of independent censoring is made, as is the assumption that the uncensored
events in the sample were not in any way dependent on one another.
The survivor function S(t) at any time point, say, tk ∈ [t(k), t(k+1)), may be es-
timated by the probability of surviving through the interval tk as well as having
92
survived through all the previous intervals [9]. Since the various events are as-
sumed to occur independently, the probability of surviving through each interval
is independent of the probabilities of surviving through all other intervals, and
hence the joint probability of surviving through all the intervals t(j), from t(1) up









for k ∈ [1, r] and t ∈ [t(k), t(k+1)).
Calculating Ŝ(t) for each interval results in a series of probability estimates,
which can then be plotted with Ŝ(t) remaining constant within each interval and
undefined after the largest event time.
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Appendix B
Derivation of Standard Errors
and Confidence Intervals for the
Survivor Function
This appendix gives the steps in the derivation of Greenwood’s formula, for the
standard error of the Kaplan-Meier estimate of the survivor function, and the
calculation of confidence intervals for the estimate, as outlined by Collett [9].
B.1 Derivation of Greenwood’s formula








which is known as Greenwood’s formula [9]. The derivation is obtained using the
Taylor series approximation to the variance of a function of a random variable,
and details are given below.








π̂j = 1− qj =
nj − dj
nj
is the estimated true probability of not experiencing an event at or before time
interval t(j) [9].













since the π̂j are conditionally uncorrelated [9].
Suppose that the number of individuals who get through the interval t(j) without
experiencing an event is a random variable Yj ∼ Bin(nj, πj), with the observed
number of survivals being Yj = nj−dj [9]. Using the known variance for a binomial
variable,












































































Taking the square root of this variance gives Greenwood’s formula, the standard
error of Ŝ(t).
96
B.2 Confidence intervals for the survivor func-
tion
Two key issues in calculating confidence intervals for the survival function are
that of determining the distribution of Ŝ(t) and dealing with values of Ŝ(t) near














using Greenwood’s formula, with zα/2 being the value of Z on the standard normal
distribution such that Φ(zα/2) = α/2.
This approach normally works well, except when the estimate Ŝ(t) is close to
0 or 1, in which case using the above formula would result in confidence limits
lying outside [0, 1] [9]. One alternative is to replace the confidence limit lying
outside this range with either 0 or 1 as appropriate, resulting in an asymmetric
interval; another approach is to transform the values using the complementary
log-log transformation—
log[−log{S(t)}]
which applies the natural logarithm to the cumulative hazard H(t) = −log{S(t)}
[9]. This transforms an estimate bounded by [0, 1] to one ranging from (−∞,+∞),
and gives 100(1− α)% confidence limits of
Ŝ(t)exp[±zα/2 s.e.{log(−log{Ŝ(t)})}]
where s.e{log(−logŜ(t))} = (logŜ(t))−1[∑kj=1 djnj(nj−dj) ]1/2 [9]. The standard error
can be derived using the Taylor approximation in a similar way to the standard
error of Ŝ(t).
Confidence limits for a dataset will need to be calculated for each “step” of the
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Kaplan-Meier survivor step function for that dataset. Bands of the confidence lim-
its can then be plotted on a graph of the estimated survivor function, and, when
using one of the above methods, are only valid for intervals of time between events,





Longitudinal mixed effects modelling (LMEM) concerns observations taken on a
sample of individuals at different points in time, and the fitting of an LMEM forms
the basis for the longitudinal conditional probability weighting (LCPW) scheme
as described in Section 3.4. This appendix outlines the theory and method of
fitting an LMEM, mainly as described in Pinheiro and Bates [37] and Laird and
Ware [26].
Three distinct sources of within-individual variation are identifiable in a longitu-
dinal study, and can be readily seen in our HIV study of interest[14]:
1. Measurement error — this is random variation introduced by the tool or
technique used to obtain the observations in the study. For example, the
CD4+ measurement from a single blood test can be thought of as a real-
ization of an underlying distribution centred on the individual’s true CD4+
level, having some degree of variation from the true level.
2. Random effects — these are unobservable effects of intrinsic heterogeneity
between individuals, such as differences in baseline CD4+ level and other
aspects of immunological function.
3. Serial correlation — this is due to time-varying responses operating within
an individual, with the degree of correlation relying on the time lag between
observations, and expected to decrease with increasing lag. Observations
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taken closer together, say monthly, are likely to be more strongly correlated
than observations taken several months apart.
In our analysis, we make the assumption that the effects of serial correlation
within individuals are dominated by a combination of random effects and mea-
surement error, and can therefore simply be incorporated into the random effect
for each individual [14]. The form of longitudinal model that we will be using is
essentially a type of multiple regression model, or more generally, a general linear
model, with the addition of random effects to represent the shared characteristics
underlying observations taken over time on the same individual.
C.1 Fixed and random effects
Longitudinal analysis is an extension of the multiple regression analysis normally
performed on cross-sectional data, which involves a single-response per individ-
ual taken at a given time point. The cross-sectional model normally takes the
form
Y = Xβ + ε, with ε ∼ N(0, σ2I),
where I is the identity matrix, with fixed effects X corresponding to the covariates
for each individual, and a vector ε of errors.
The covariates are considered to be fixed effects as their coefficients represent
the average influence, over all individuals in the sample, of the covariate on the
response Y [18]. They track characteristics across individuals, but do not take
any inherent differences between individuals into account which could affect the
influence of the covariates.
When multiple observations are taken on each individual over time, however,
individual-specific variation on the influences of the covariates becomes readily
apparent and measurable, and random effects for each individual in the study
are used to incorporate this. Inferences about the fixed effects can then be gen-
eralized to the larger population, since within-individual effects have been ac-
counted for. The goal of longitudinal analysis, then, is to model the response
yij in terms of covariates xi for individuals i = 1, . . . , n, each with observations
j = 1, . . . ,mi.
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C.1.1 Regression model setup with mixed effects
The longitudinal mixed effects model (LMEM) is a linear combination of fixed
and random effects, and takes the following form adapted from Laird and
Ware [26]. For each individual, we take measurements on response variables
yi = (yi1, . . . , yimi)′, p main effects, and q random, or individual-specific effects.
This produces the regression equation for each individual
yi = Xiβ + Zibi + εi
where ε ∼ N(0, σ2I), and errors are mutually independent.
The fixed effects coefficients β = [β1, . . . , βp]′ take the same value for all observa-
tions on all individuals, and correspond to the fixed effect covariates. The fixed







The random effect coefficients bi = [bi1, . . . , biq]′ vary by individual, taking the
same value for all observations on the same individuals. They are random variables
assumed to follow a multivariate normal distribution, and sum to zero across
individuals. They correspond to the random effects Zi for the observations on
each individual.
The bi are assumed to be distributed N(0,D), being independent of each other
and of the errors εi [26], where D is positive definite. For fixed β, the marginal
distribution of yi is normal with mean Xiβ and variance-covariance matrix given
by σ2Ini +Cov(Zibi), equivalent to σ2Ini +ZiDZ′i [26]. Since individuals sampled
are assumed mutually independent, the yi’s are independent of each other.
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C.2 Parameter estimation
The parameters requiring estimation in the LME model are β, the fixed effects
parameter vector, and σ2, the error variance. We define a “relative precision
factor” ∆ that satisfies
σ2D−1 = ∆′∆.
Precision is the inverse of the variance, and so ∆ measures the ratio of the
precision of the random effects, D−1 to the precision of the error εi, given by σ2.
Furthermore, we define a q×1 parameter vector θ which is some parameterization
of ∆ and hence of εi and D. Hence, θ contains information about the structures
of the errors and the random effects.
The random effects vectors bi are not parameters in the strictest sense, as their
values apply to only to their corresponding individuals and not to the whole
population, but they can be estimated using the estimate for θ.
In Chapter 2, we built up a partial likelihood function for Cox regression using the
probabilities for each individual of experiencing the event of interest at some time
point, which is a method utilized in semi-parametric modelling where the response
is not assumed to follow a particular probability distribution. LME modelling is
usually parametric, where we assume that the responses and parameters follow
well-defined underlying distributions. Hence, the maximum likelihood estimation
for LME modelling is comparatively more in line with classical likelihood theory,
although some profiling of the likelihood is done to aid in computational efficiency,
by making a likelihood of several variables one of a single variable.
The derivation of the likelihood function and optimization equations for the
LMEM is covered in detail by Pinheiro and Bates [37], and will not be included
here. We give the resulting equations and explain how they are optimized to
obtain the required estimates.
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The profiled log-likelihood for MLE
The LMEM likelihood function is given by
L(β,θ, σ2|y) = 1(2πσ2)N/2 exp











 , X̃i =
 Xi
0




are the augmented data vectors and model matrices.
(C.1) can be run directly in an optimization routine to calculate the ML esti-
mates of β, θ and σ, or, using orthogonal triangular decompositions as outlined
below, the above likelihood could be profiled in order to make it a function of θ
only.
Any matrix of full rank can be decomposed into the product of an orthogonal
transformation matrix Q and a matrix whose upper square block is an upper
triangular, non-singular matrix R; this is also known as a QR decomposition. For
the matrix Q, QQ′ = Q′Q = I, where I is the identity matrix, and multiplying
Q by any compatible vector preserves the norm of that vector [37].
Applying this to the augmented model matrices from (C.2) for each individual i
gives the decomposition [37]
Q′(i)
 Zi Xi yi
∆ 0 0
 =
 R11(i) R10(i) c1(i)
0 R00(i) c0(i)
 ,
where Q′(i) is an (mi + q)× (mi + q) orthogonal matrix. The block columns of the
transformed matrix correspond to the random effects, fixed effects and response
respectively.
For any given θ, the ML estimates for β and σ2 are















L(θ|y) = logL(β̂(θ),θ, σ̂2(θ)|y)






can be maximized to get an estimate for θ. This estimate can then be substituted
into (C.3) to get estimates for β and σ2.
The best linear unbiased predictors, or BLUPs, of bi can then be found us-
ing
b̂i(θ̂) = R−111(i)(c1(i) −R10(i)β̂(θ̂)) (C.5)
This is akin to taking the inverse of the random effects and multiplying by the
response less the fixed effects, albeit all using Q-transformed matrices and vec-
tors.
The profiled log-likelihood can be run through an iterative process such as Newton
Raphson or the Expectation-Maximization algorithm, and the substitutions made
to estimate the other parameters and predictors as described above.
C.2.1 Problems with the maximum likelihood estima-
tor
The maximum likelihood approach can be at risk of producing inconsistent esti-
mators if the form of the design matrices Xi are incorrect – that is, if the fixed
effects specified for the model produce an inadequate fit. If, in order to correct
this problem, a saturated model is fitted which models the mean observation
for each observation time within the study (which should theoretically produce
a near-perfect fit), ML estimation tends to produce estimates for the variance
parameters that are biased downward [14, 37].
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Thus, restricted maximum likelihood (REML) estimation, as reviewed by Harville
[19], has come into recent favour, and for the above reasons we have chosen to
use it in our implementation of the LCPW scheme.
C.2.2 Restricted maximum likelihood (REML) estima-
tion
An intuitive description of REML estimation is the Bayesian interpretation given
in the seminal paper by Laird and Ware [26]. For the conditional distribution of
the response given by yi ∼ N(Xiβ+Zibi, σ2I), we assume some underlying distri-
bution for the fixed effects β, say β ∼ N(0,Γ), making the marginal distribution
of the response yi ∼ N(0,XiΓX′i + ZiDZ′i + σ2I).
While we have some information about θ, being some parameterization of σ2
and D which can be gleaned from the data, we have no information about Γ.
Laird and Ware [26] suggest assuming an infinite variance for β, hence letting
Γ−1 = 0, and maximizing the limiting (i.e. Γ−1 → 0) marginal likelihood L(θ|y),
equivalent to the restricted maximum likelihood or REML.
We could think of this as integrating β out of the conditional likelihood for y as





The log-restricted likelihood is given by [37]
LR(θ, σ2|y) = logL(θ, σ2|y)















which, when substituted into (C.6), we get the profiled log-restricted likeli-
hood,














Comparing this to the profiled unrestricted log-likelihood in (C.4), the profiled
log-restricted likelihood is similar in that it contains a constant, a scaled logarithm
of the error sum of squares ‖c−1‖, and a sum of ratios of the log-determinants
[37]. We note, however, that the scaling factor in the constant and scaled error
sum of squares is N − p in the log-restricted likelihood, while it is N in the
unrestricted log-likelihood. Also, the log-restricted likelihood has an extra term,
log|R00|, which relates to the determinant of the transformed matrix pertaining
to the fixed effects. This corresponds to the fixed effects having been integrated
out of the restricted likelihood.
The REML estimation procedure consists of optimizing the profiled log-restricted
likelihood in (C.7) with respect to θ first, and then using the estimate to calculate
σ̂2R(θ̂R). The calculation of the estimates for β and bi are done using the ML
formulae, by applying (C.3) and (C.5) respectively.
C.2.3 Approximate distributions of the estimates
Pinheiro [36] showed that in practice, both the ML and REML estimates for
θ, σ2 and β are consistent and asymptotically normal, with their approximate
variance-covariance matrix given by the inverse of the Fisher Information matrix
corresponding to the profiled log-likelihood for ML estimates and the profiled













the information matrix I is block-diagonal, and the estimates of β are asymp-













 , I−1(θ, σ)
 ,
where
I−1(θ, σ) = −






and by L, we mean either the profiled log-likelihood L if using MLEs, or the
profiled log-restricted likelihood LR if using REML estimates [37].
C.2.4 Optimization routines for parameter estima-
tion
Newton-Raphson has been introduced in previous chapters as the standard itera-
tive technique for optimizing the Cox likelihood, and can also be used for the pro-
filed likelihoods in ML or REML estimation. When starting with an estimate close
to the optimum, the Newton-Raphson algorithm converges very quickly. However,
the iterations can be unstable when starting with an estimate far from the opti-
mum, and the calculations, in general, are computationally expensive.
Less computationally burdensome is the Expectation-Maximization, or EM algo-
rithm, which can also be used for both profiled likelihoods, and is particularly
popular in REML estimation. In applying EM iterations to the LME model, we
regard the random effects, bi, as unobserved data, following some unknown dis-
tribution, and cycle through two distinct steps. In the expectation-, or E-step,
the current estimate (or starting estimate if this is the first iteration) of θ is used
to evaluate the distribution of b|y, and given this conditional distribution, an ex-
pectation of the profiled log-likelihood is derived. In the following maximization-,
or M-step, the expected profiled log-likelihood from the E-step is maximized with
respect to θ, to produce a new estimate of θ.
The EM algorithm, unlike Newton-Raphson, brings estimates into the region of
the optimum very quickly, but tends to iterate much more slowly as the estimates
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near the optimum. Hence, a hybrid approach is commonly utilized in practice,
consisting of several iterations using the EM algorithm to bring the starting es-
timates into the region of the optimum, followed by Newton-Raphson iterations
to bring about full convergence to the optimum [37].
C.3 Evaluating significance and checking model
fit
In Cox regression (Chapter 2), likelihood ratio (LR) tests for the comparison
of nested models were the preferred method of evaluating the significance of
regression parameters, over Wald tests conditioned on the distribution of the
parameter estimates. In LME regression with random effects, however, parametric
significance tests are preferred for the fixed effects parameters, and caution should
be taken in using LR tests to compare LME models [37].
For models fit by maximum likelihood estimation, LR tests can be used to com-
pare models with nested fixed effects structures, although this is not recommended
by Pinheiro and Bates [37], who showed through simulations that the p-values
derived in such LR tests can be much smaller than p-values derived from condi-
tional parametric tests, such as F-tests and t-tests, on the same data, and warned
against the anti-conservative nature of the test. Since the conditional distribu-
tions of the MLE and REML estimates that are conditioned on estimates of θ are
exact, conditional t-tests, which are included with their corresponding p-values
in the summaries of LME output in R, are much more accurate than LR tests
and can be easily accessed and interpreted.
Likelihood ratio tests can be used to compare models fit by REML which have
nested random effects structures, but both models must be fit by REML and
have identical fixed effects structures. The term in the profiled log-restricted like-
lihood, log|R00|, which is not in the unrestricted log-likelihood, changes with
different fixed effects structures which change the Xi. We recall that R00 is the
Q-transformed matrix corresponding to the Xi.
Due to the limitations of likelihood ratio testing for LME models, it is preferable
to use the Akaike Information Criterion (AIC) and Bayesian Information Crite-
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rion (BIC) to measure and compare model fit, using the profiled log-likelihoods
under ML or REML estimation. They are given by [37]
AIC = −2 L(θ̂|y) + 2npar and
BIC = −2 L(θ̂|y) + nparlog(N)
with npar being the number of parameters in the model. Both measure the trade-
off between the goodness-of-fit of the model and the number of parameters, and
in adding the npar term, both impose a penalty for overfitting, although the BIC
penalty is greater.
The AIC and BIC have the advantage in that the models being compared do
not have to be nested. However, similar to LR tests, they only give a measure of
model fit relative to other models, and not an absolute measure with which to
judge a model as good or poor.
Since the LMEMs being fitted for our implementation of the LCPW scheme to
simulated and real data are relatively simple, we do not consider the AIC and
BIC further. However, their use is recommended for analysts seeking to imple-
ment the LCPW scheme, and we check the robustness of the LCPW scheme to
model misspecification (as judged by the residual standard deviation σ̂) through
simulations in Chapter 4.
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